{"content":"<li class=\"n-box-item date-title\" data-end=\"1507953599\" data-start=\"1507867200\" data-txt=\"Monday, December 23, 2019\">Friday, October 13, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3301052\" data-ts=\"1507931329\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3301052-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/PETX' title='Aratana Therapeutics'>PETX</a> <font color='green'>+8.6%</font>. <a href='https://seekingalpha.com/symbol/TECK' title='Teck Resources Limited'>TECK</a> <font color='green'>+2.1%</font>. <a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a> <font color='green'>+2.1%</font>. <a href='https://seekingalpha.com/symbol/TERP' title='TerraForm Power, Inc.'>TERP</a> <font color='green'>+1.7%</font>. <a href='https://seekingalpha.com/symbol/MSB' title='Mesabi Trust'>MSB</a> <font color='green'>+1.5%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> ITEK <font color='red'>-6.9%</font>. <a href='https://seekingalpha.com/symbol/ISRG' title='Intuitive Surgical, Inc.'>ISRG</a> <font color='red'>-3.7%</font>. <a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a> <font color='red'>-2.0%</font>. <a href='https://seekingalpha.com/symbol/ACRX' title='AcelRx Pharmaceuticals, Inc.'>ACRX</a> <font color='red'>-1.2%</font>. <a href='https://seekingalpha.com/symbol/SUPV' title='Grupo Supervielle'>SUPV</a> <font color='red'>-1.0%.</font></li> </ul><div class=\"tiny-share-widget\" data-id=\"3301052\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$PETX $TECK $MNKD - After Hours Gainers / Losers https://seekingalpha.com/news/3301052-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3301052-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3301049\" data-ts=\"1507929155\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3301049-weekly-etf-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a> <font color='green'>+5.3%</font>. <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a> <font color='green'>+4.1%</font>. <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a> <font color='green'>+4.0%</font>. <a href='https://seekingalpha.com/symbol/EWY' title='iShares MSCI South Korea Capped ETF'>EWY</a> <font color='green'>+3.7%</font>. <a href='https://seekingalpha.com/symbol/SIVR' title='Aberd Std Silvr Shs'>SIVR</a> <font color='green'>+3.7%</font>.</li>     <li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/VXX' title='iPath S&P 500 VIX Short-Term Futures ETN'>VXX</a> <font color='red'>-4.7%</font>. <a href='https://seekingalpha.com/symbol/AMJ' title='JPMorgan Alerian MLP Index ETN'>AMJ</a> <font color='red'>-1.9%</font>. <a href='https://seekingalpha.com/symbol/URA' title='Global X Uranium ETF'>URA</a> <font color='red'>-1.1%</font>. <a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a> <font color='red'>-0.8%</font>. <a href='https://seekingalpha.com/symbol/UUU' title='Universal Security Instruments, Inc'>UUU</a> <font color='red'>-0.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3301049\" data-linked=\"Weekly ETF Gainers / Losers\" data-tweet=\"$OIL $UNG $USO - Weekly ETF Gainers / Losers https://seekingalpha.com/news/3301049-weekly-etf-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3301049-weekly-etf-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3301042\" data-ts=\"1507927572\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRXC\" target=\"_blank\">TRXC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3301042-fda-clears-tranenterixs-robotic-surgery-system-senhance-shares-ahead-60-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA clears TranEnterix&#39;s robotic surgery system Senhance; shares ahead 60% after hours</a></h4><ul><li>TransEnterix (NYSEMKT:<a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a>) is up&nbsp;<font color='green'>60%</font>&nbsp;after hours on robust volume in response the the FDA's 510(k) <a href=\"https://seekingalpha.com/pr/16968355-fda-clears-new-robotically-assisted-surgical-device-adult-patients\" target=\"_blank\">clearance </a>for its <a href=\"https://www.transenterix.com/\" target=\"_blank\">Senhance System</a>, a robotically assisted surgical device used in minimally invasive procedures, specifically the accurate control of laparoscopic instruments.</li></ul><div class=\"tiny-share-widget\" data-id=\"3301042\" data-linked=\"FDA clears TranEnterix&#39;s robotic surgery system Senhance; shares ahead 60% after hours\" data-tweet=\"$TRXC - FDA clears TranEnterix&#39;s robotic surgery system Senhance; shares ahead 60% after hours https://seekingalpha.com/news/3301042-fda-clears-tranenterixs-robotic-surgery-system-senhance-shares-ahead-60-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3301042-fda-clears-tranenterixs-robotic-surgery-system-senhance-shares-ahead-60-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>81&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3301027\" data-ts=\"1507925922\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PETX\" target=\"_blank\">PETX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3301027-aratana-trading-halted-pending-news-to-resume-4-35-et-entyce-product-launch-underway\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aratana trading halted pending news, to resume at 4:35 ET; ENTYCE product launch underway</a></h4><ul><li>Nasdaq has <a href=\"http://www.nasdaqtrader.com/trader.aspx?id=tradehalts\" target=\"_blank\">suspended trading </a>in Aratana Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PETX' title='Aratana Therapeutics'>PETX</a>) pending the release of news. Trading is set to resume at 4:35 pm ET.</li><li><strong>Update</strong>: The company <a href=\"https://seekingalpha.com/pr/16968315-aratana-therapeutics-announces-launch-entyce-capromorelin-oral-solution\" target=\"_blank\">announced</a> that it is launching ENTYCE (capromorelin oral solution) for appetite stimulation in dogs to U.S. veterinarians.</li></ul><div class=\"tiny-share-widget\" data-id=\"3301027\" data-linked=\"Aratana trading halted pending news, to resume at 4:35 ET; ENTYCE product launch underway\" data-tweet=\"$PETX - Aratana trading halted pending news, to resume at 4:35 ET; ENTYCE product launch underway https://seekingalpha.com/news/3301027-aratana-trading-halted-pending-news-to-resume-4-35-et-entyce-product-launch-underway?source=tweet\" data-url=\"https://seekingalpha.com/news/3301027-aratana-trading-halted-pending-news-to-resume-4-35-et-entyce-product-launch-underway\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3301024\" data-ts=\"1507925317\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LPCN\" target=\"_blank\">LPCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3301024-lipocine-registers-150m-mixed-shelf-offering-shares-down-8-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lipocine registers $150M mixed shelf offering; shares down 8% after hours</a></h4><ul><li>Lipocine (NASDAQ:<a href='https://seekingalpha.com/symbol/LPCN' title='Lipocine Inc.'>LPCN</a>) is down&nbsp;<font color='red'>8%</font>&nbsp;after hours on increased volume in apparent response to its filing of an <a href=\"https://www.sec.gov/Archives/edgar/data/1535955/000114420417052424/tv476905_s3.htm\" target=\"_blank\">S-3</a> for a $150M mixed shelf offering. Proceeds will be used for general corporate purposes.</li></ul><div class=\"tiny-share-widget\" data-id=\"3301024\" data-linked=\"Lipocine registers $150M mixed shelf offering; shares down 8% after hours\" data-tweet=\"$LPCN - Lipocine registers $150M mixed shelf offering; shares down 8% after hours https://seekingalpha.com/news/3301024-lipocine-registers-150m-mixed-shelf-offering-shares-down-8-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3301024-lipocine-registers-150m-mixed-shelf-offering-shares-down-8-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3301019\" data-ts=\"1507924629\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANIP\" target=\"_blank\">ANIP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3301019-takeover-rumor-du-jour-ani-pharma-shares-ahead-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Takeover rumor du jour - ANI Pharma; shares ahead 10%</a></h4><ul><li>ANI Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ANIP' title='ANI Pharmaceuticals, Inc.'>ANIP</a> <font color='green'>+9.7%</font>) is up average volume on (drumroll please) takeover chatter. Shares were up almost&nbsp;<font color='green'>20%</font>&nbsp;before retracing.</li><li>The company sells generic drugs and provides contract manufacturing services.</li></ul><div class=\"tiny-share-widget\" data-id=\"3301019\" data-linked=\"Takeover rumor du jour - ANI Pharma; shares ahead 10%\" data-tweet=\"$ANIP - Takeover rumor du jour - ANI Pharma; shares ahead 10% https://seekingalpha.com/news/3301019-takeover-rumor-du-jour-ani-pharma-shares-ahead-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3301019-takeover-rumor-du-jour-ani-pharma-shares-ahead-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3301018\" data-ts=\"1507924536\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZN\" target=\"_blank\">ZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3301018-zion-oilplus-10-on-drilling-update-start-of-new-unit-program\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zion Oil +10% on drilling update, start of new unit program</a></h4><ul>     <li>Zion Oil &amp;&nbsp;Gas (<a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color='green'>+10%</font>) surges after a new <a href=\"https://seekingalpha.com/pr/16967673-zion-oil-and-gas-israel-drilling-update-new-offering-launch\" target=\"_blank\">Israel drilling update</a> says the company encountered four separate zones worthy of possible production testing during drilling of its Megiddo-Jezreel No. 1 well.</li><li>ZN also announces the start of the sale of $250 equity units that contain ZN common shares - the number determined by dividing the average of its high and low stock price on the purchase date into $250 - and warrants to buy up to 15 more shares at $1 each.</li></ul><div class=\"tiny-share-widget\" data-id=\"3301018\" data-linked=\"Zion Oil +10% on drilling update, start of new unit program\" data-tweet=\"$ZN - Zion Oil +10% on drilling update, start of new unit program https://seekingalpha.com/news/3301018-zion-oilplus-10-on-drilling-update-start-of-new-unit-program?source=tweet\" data-url=\"https://seekingalpha.com/news/3301018-zion-oilplus-10-on-drilling-update-start-of-new-unit-program\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3301016\" data-ts=\"1507924194\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABC\" target=\"_blank\">ABC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3301016-60-minutes-report-stocked-selloff-in-drug-distributors-overblown-cowen\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">60 Minutes report-stocked selloff in drug distributors overblown - Cowen</a></h4><ul><li>Cowen says the selling pressure on the big drug wholesalers, AmerisourceBergen (<a href='https://seekingalpha.com/symbol/ABC' title='AmerisourceBergen Corporation'>ABC</a> <font color='red'>-1.7%</font>), Cardinal Health (<a href='https://seekingalpha.com/symbol/CAH' title='Cardinal Health Inc.'>CAH</a> <font color='red'>-1.9%</font>) and McKession (<a href='https://seekingalpha.com/symbol/MCK' title='McKesson Corporation'>MCK</a> <font color='red'>-2.1%</font>), is overdone.</li><li>Analyst Charles Rhyee says the distributors have had \"robust suspicious order monitoring systems\" in place since the mid-2000s after allegations of improper reporting. He adds that it is \"unlikely\" that they were uncooperative with the government regarding fighting the opioid epidemic.</li><li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3300950-60-minutes-run-piece-opioid-epidemic-critical-suppliers-sunday-drug-distributors-pressure\" target=\"_blank\">60 Minutes to run piece on opioid epidemic critical of suppliers this Sunday; drug distributors under pressure</a> (Oct. 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3301016\" data-linked=\"60 Minutes report-stocked selloff in drug distributors overblown - Cowen\" data-tweet=\"$ABC $ABC $CAH - 60 Minutes report-stocked selloff in drug distributors overblown - Cowen https://seekingalpha.com/news/3301016-60-minutes-report-stocked-selloff-in-drug-distributors-overblown-cowen?source=tweet\" data-url=\"https://seekingalpha.com/news/3301016-60-minutes-report-stocked-selloff-in-drug-distributors-overblown-cowen\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3301015\" data-ts=\"1507923718\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VHC\" target=\"_blank\">VHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3301015-virnetx-shares-plunge-ahead-of-court-document-release-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VirnetX shares plunge ahead of court document release (update)</a></h4><ul><li>VirnetX Holding (NYSEMKT:<a href='https://seekingalpha.com/symbol/VHC' title='VirnetX Holding Corporation'>VHC</a>) shares&nbsp;<font color='red'>plunge 13.29%</font>&nbsp;as investors await the final court document from its long-running patent dispute with Apple.</li><li>Last month, <a href=\"https://twitter.com/TradeHawk/status/913940155739783170\" target=\"_blank\">TradeHawk</a> tweeted the final judgment order from the case but the verdict was sealed to give the companies time to redact the judgment for release.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3298678-virnetx-shares-33-percent-potential-apple-case-ruling\" target=\"_blank\">VirnetX shares up 33% on potential Apple case ruling</a> (Oct. 2)</li><li>Update: Apple and VirnetX have proposed a <a href=\"https://www.streetinsider.com/Options/VirnetX+%28VHC%29+volatility+increases+on+report+of+proposed+trial+date+in+March+for+patent+case/13388730.html\" target=\"_blank\">March trial date</a> for the second patent trial, according to Bloomberg.</li><li>VHC shares are&nbsp;<font color='green'>up 15.62%</font>&nbsp;aftermarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3301015\" data-linked=\"VirnetX shares plunge ahead of court document release (update)\" data-tweet=\"$VHC - VirnetX shares plunge ahead of court document release (update) https://seekingalpha.com/news/3301015-virnetx-shares-plunge-ahead-of-court-document-release-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3301015-virnetx-shares-plunge-ahead-of-court-document-release-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3301014\" data-ts=\"1507923643\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGCO\" target=\"_blank\">AGCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3301014-agco-should-be-avoided-no-recovery-in-global-tractor-market-bofa-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AGCO should be avoided with no recovery in global tractor market, BofA says</a></h4><ul>     <li>AGCO&nbsp;(<a href='https://seekingalpha.com/symbol/AGCO' title='AGCO Corporation'>AGCO</a> <font color='red'>-4.1%</font>) is sharply lower of BofA&nbsp;Merrill Lynch <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/10/10176317/bank-of-america-advises-selling-agco-shares\" target=\"_blank\">downgrades</a> shares to Underperform from Neutral with a $70 price target, trimmed from $75, citing data that suggests the global tractor market recovery is not materializing.</li>     <li>While AGCO expected flat Brazilian demand in H2 2017 following a sharp recovery in H1, BofA's Ross Gilardi says tractor sales in Brazil instead fell during Q3; also, recent tractor data from Europe, which accounts for 80% of AGCO's EBIT, is \"incrementally weaker,\" and North America suffered a 14% decline in HHP tractor sales in September on top of a 2% drop in August.</li>     <li>Gilardi notes AGCO shares were trading at an all-time high even as global tractor market data remained negative.</li></ul><div class=\"tiny-share-widget\" data-id=\"3301014\" data-linked=\"AGCO should be avoided with no recovery in global tractor market, BofA says\" data-tweet=\"$AGCO - AGCO should be avoided with no recovery in global tractor market, BofA says https://seekingalpha.com/news/3301014-agco-should-be-avoided-no-recovery-in-global-tractor-market-bofa-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3301014-agco-should-be-avoided-no-recovery-in-global-tractor-market-bofa-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3301012\" data-ts=\"1507923323\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OREX\" target=\"_blank\">OREX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3301012-orexigen-prevails-over-generic-challenger-in-contrave-infringement-case-shares-down-6-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Orexigen prevails over generic challenger in Contrave infringement case; shares down 6% in volatile trading</a></h4><ul><li>The trading range in thinly traded nano cap Orexigen Therapeutics (<a href='https://seekingalpha.com/symbol/OREX' title='Orexigen Therapeutics, Inc.'>OREX</a> <font color='red'>-5.9%</font>) has been abnormally wide today on a robust 60x surge in volume. Intraday, shares were up&nbsp;<font color='green'>14%</font>&nbsp;at their peak and down&nbsp;<font color='red'>18%</font>&nbsp;at their low.</li><li>The company <a href=\"https://seekingalpha.com/pr/16968275-orexigen-announces-favorable-decision-u-s-district-court-patent-litigation-confirming\" target=\"_blank\">announced</a> a favorable ruling in a patent infringement case against Actavis (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color='red'>-1.1%</font>) who was seeking to market a generic version of Contrave (naltrexone HCl/bupropion HCl extended release), saying its current exclusivity will be maintained through 2030.</li></ul><div class=\"tiny-share-widget\" data-id=\"3301012\" data-linked=\"Orexigen prevails over generic challenger in Contrave infringement case; shares down 6% in volatile trading\" data-tweet=\"$OREX $OREX $TEVA - Orexigen prevails over generic challenger in Contrave infringement case; shares down 6% in volatile trading https://seekingalpha.com/news/3301012-orexigen-prevails-over-generic-challenger-in-contrave-infringement-case-shares-down-6-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3301012-orexigen-prevails-over-generic-challenger-in-contrave-infringement-case-shares-down-6-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3301011\" data-ts=\"1507922571\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GEL\" target=\"_blank\">GEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3301011-genesis-energy-slides-to-52-week-low-analysts-somewhat-upbeat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genesis Energy slides to 52-week low but analysts somewhat upbeat</a></h4><ul>     <li>Genesis Energy (<a href='https://seekingalpha.com/symbol/GEL' title='Genesis Energy, L.P.'>GEL</a> <font color='red'>-3.4%</font>) tumbles to a 52-week low, extending <a href=\"https://seekingalpha.com/news/3300748-genesis-energy-3-percent-distribution-cut\" target=\"_blank\">yesterday's steep drop</a> after its 31% quarterly distribution cut to $0.50 from ~$0.73 wiped out nearly five years of steady growth.</li>     <li>Analysts jump in today with stock price target cuts but remain reasonably optimistic:&nbsp;Mitsubishi <a href=\"http://thefly.com/thestreet/realmoney/index.php/GELid2622351/GEL-Genesis-Energy-price-target-lowered-to--from--at-MUFG\" target=\"_blank\">trims its GEL target</a> to $29 from $35 but believes the distribution cut puts the partnership on firmer financial footing, while Janney <a href=\"http://thefly.com/thestreet/realmoney/index.php/GELid2622596/GEL-Genesis-Energy-price-target-lowered-to--from--at-Janney-Capital\" target=\"_blank\">cuts its target</a> to $30 from $37 but keeps its Buy rating, saying the distribution cut will allow for faster reduction of debt levels and opportunistic deployment of excess capital.</li>     <li>Barclays also cuts its price target - to $27 from $31 - but <a href=\"http://thefly.com/thestreet/realmoney/index.php/GELid2622332/GEL-Genesis-Energy-upgraded-to-Equal-Weight-from-Underweight-at-Barclays\" target=\"_blank\">upgrades</a> shares to Equal Weight from Underweight, saying the distribution cut is a \"logical move\" that puts the partnership on better footing to de-lever and grow the business.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3301011\" data-linked=\"Genesis Energy slides to 52-week low but analysts somewhat upbeat\" data-tweet=\"$GEL - Genesis Energy slides to 52-week low but analysts somewhat upbeat https://seekingalpha.com/news/3301011-genesis-energy-slides-to-52-week-low-analysts-somewhat-upbeat?source=tweet\" data-url=\"https://seekingalpha.com/news/3301011-genesis-energy-slides-to-52-week-low-analysts-somewhat-upbeat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3301009\" data-ts=\"1507921794\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TOSBF\" target=\"_blank\">TOSBF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3301009-toshiba-wants-to-mend-fences-western-digital-on-fab-6-investment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Toshiba wants to mend fences with Western Digital on Fab 6 investment</a></h4><ul><li>        Toshiba Memory (<a href='https://seekingalpha.com/symbol/TOSBF' title='Toshiba Corp.'>OTCPK:TOSBF</a>, <a href='https://seekingalpha.com/symbol/TOSYY' title='Toshiba Corp. ADR'>OTCPK:TOSYY</a>) president Yasuo Naruke <a href=\"https://asia.nikkei.com/Spotlight/Toshiba-in-Turmoil/Toshiba-holds-out-olive-branch-to-Western-Digital-for-chip-investment?page=1\" target=\"_blank\">discusses</a> the company&rsquo;s investment plans at a news conference today.</li><li>               The plans include capital investments of $2.68B per year to ramp up production to meet a memory shortage.&nbsp;</li><li>               Toshiba is currently working on the Fab 6 facility with nearby land set aside for a potential Fab 7. &nbsp;&nbsp;</li><li>               As reported earlier, Toshiba has renewed talks with Western Digital (NYSE:<a href='https://seekingalpha.com/symbol/WDC' title='Western Digital Corporation'>WDC</a>) about a possible joint investment on chip lines because of the cost. Naruke said it &ldquo;would not be impossible&rdquo; for Toshiba to go it alone.&nbsp;</li><li>               Naruke says the companies can collaborate to &ldquo;take advantage of economies of scale&rdquo; and that, despite the legal disputes, Toshiba wants to &ldquo;work on mending fences quickly.&rdquo;&nbsp;</li><li>Western Digital shares are&nbsp;<font color='green'>up 2.2%.</font>&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3300900-toshiba-talking-western-digital-chip-line-investment\" target=\"_blank\">Toshiba talking to Western Digital about chip line investment</a> (Oct. 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3301009\" data-linked=\"Toshiba wants to mend fences with Western Digital on Fab 6 investment\" data-tweet=\"$TOSBF $TOSBF $TOSYY - Toshiba wants to mend fences with Western Digital on Fab 6 investment https://seekingalpha.com/news/3301009-toshiba-wants-to-mend-fences-western-digital-on-fab-6-investment?source=tweet\" data-url=\"https://seekingalpha.com/news/3301009-toshiba-wants-to-mend-fences-western-digital-on-fab-6-investment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3301006\" data-ts=\"1507921148\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3301006-technology-top-gainers-losers-of-2-55-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2:55 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NETE' title='Net Element International, Inc.'>NETE</a> <font color='green'>+46%</font>. <a href='https://seekingalpha.com/symbol/MARK' title='Remark Holdings, Inc.'>MARK</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/SOHU' title='Sohu.com Inc.'>SOHU</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/OCC' title='Optical Cable Corporation'>OCC</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/VHC' title='VirnetX Holding Corporation'>VHC</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/AAOI' title='Applied Optoelectronics, Inc.'>AAOI</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/SIFY' title='Sify Technologies Limited'>SIFY</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/RNVA' title='Rennova Health, Inc.'>OTCPK:RNVA</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/DDD' title='3D Systems Corp.'>DDD</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3301006\" data-linked=\"Technology - Top Gainers / Losers as of 2:55 pm\" data-tweet=\"$NETE $MARK $HMNY - Technology - Top Gainers / Losers as of 2:55 pm https://seekingalpha.com/news/3301006-technology-top-gainers-losers-of-2-55-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3301006-technology-top-gainers-losers-of-2-55-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3301002\" data-ts=\"1507919847\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCG\" target=\"_blank\">PCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3301002-pg-and-e-extends-losses-following-fire-liability-disclosure-shares-nowminus-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PG&amp;E extends losses following fire liability disclosure; shares now -11%</a></h4><ul>     <li>Pacific Gas &amp; Electric (<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a> <font color='red'>-10.7%</font>) slumps to lows of the day after saying in an <a href=\"https://seekingalpha.com/filing/3727677\" target=\"_blank\">SEC filing</a> that \"it is currently is unknown whether the utility would have any liability associated\" with the catastrophic northern California <a href=\"https://seekingalpha.com/news/3300958-pg-and-e-minus-7-percent-concerns-grow-potential-link-california-wildfires\" target=\"_blank\">fires</a> that have broken out in recent days.</li>     <li>PG&amp;E says it has ~$800M in liability insurance for potential losses that may result from the fires, but \"if the amount of insurance is insufficient to cover the utility's liability or if insurance is otherwise unavailable, PG&amp;E&rsquo;s and the utility&rsquo;s financial condition or results of operations could be materially affected.\"</li><li>Shares hit a new 52-week low today and have shed 16% this week.</li></ul><div class=\"tiny-share-widget\" data-id=\"3301002\" data-linked=\"PG&amp;E extends losses following fire liability disclosure; shares now -11%\" data-tweet=\"$PCG - PG&amp;E extends losses following fire liability disclosure; shares now -11% https://seekingalpha.com/news/3301002-pg-and-e-extends-losses-following-fire-liability-disclosure-shares-nowminus-11?source=tweet\" data-url=\"https://seekingalpha.com/news/3301002-pg-and-e-extends-losses-following-fire-liability-disclosure-shares-nowminus-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3301001\" data-ts=\"1507919488\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLCO\" target=\"_blank\">MLCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3301001-melco-resorts-increases-activity-in-japan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Melco Resorts increases activity in Japan</a></h4><ul>     <li>Melco Resorts &amp; Entertainment (<a href='https://seekingalpha.com/symbol/MLCO' title='Melco Resorts & Entertainment Limited ADR'>MLCO</a> <font color='red'>-1.1%</font>) is increasing its presence in Japan as it preps to make a <a href=\"http://www.ggrasia.com/melco-resorts-ups-japan-ties-ahead-of-likely-casino-bid/\" target=\"_blank\">bid</a> for a casino license in the nation, according to GGRAsia.</li>     <li>The company is becoming more active in Japan&rsquo;s business and tourism sectors.</li><li>By most estimates, the first casinos are likely to open in Japan in about seven or eight years.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3301001\" data-linked=\"Melco Resorts increases activity in Japan\" data-tweet=\"$MLCO - Melco Resorts increases activity in Japan https://seekingalpha.com/news/3301001-melco-resorts-increases-activity-in-japan?source=tweet\" data-url=\"https://seekingalpha.com/news/3301001-melco-resorts-increases-activity-in-japan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300999\" data-ts=\"1507918077\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300999-financials-top-5-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 2:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PN' title='Patriot National, Inc.'>PN</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/FRSX' title='Foresight Autonomous Holdings Ltd.'>FRSX</a> <font color='green'>+15%</font>.<a href='https://seekingalpha.com/symbol/RE' title='Everest Re Group Ltd.'>RE</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/IHC' title='Independence Holding Company'>IHC</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MLP' title='Maui Land & Pineapple Company, Inc.'>MLP</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/FRC' title='First Republic Bank'>FRC</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/BCRH' title='Blue Capital Reinsurance Holdings Ltd.'>BCRH</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3300999\" data-linked=\"Financials - Top 5 Gainers / Losers as of 2:00 PM\" data-tweet=\"$PN $FRSX $RE - Financials - Top 5 Gainers / Losers as of 2:00 PM https://seekingalpha.com/news/3300999-financials-top-5-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3300999-financials-top-5-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300997\" data-ts=\"1507917694\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300997-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/NE' title='Noble Corporation plc'>NE</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SSRM' title='SSR Mining Inc'>SSRM</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/WLB' title='Westmoreland Coal Co'>WLB</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/EMES' title='Emerge Energy Services LP'>EMES</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3300997\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$ZN $CLF $MT - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3300997-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3300997-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300994\" data-ts=\"1507916771\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300994-valeant-down-4-wells-fargo-bear-questions-accounting\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valeant down 4% as Wells Fargo bear questions accounting</a></h4><ul><li>At issue is a lawsuit filed by Depomed over an alleged $20M in unpaid royalties. The amount is hardly worth the bother, <a href=\"http://www.barrons.com/articles/why-valeant-is-dropping-1507913812\" target=\"_blank\">but Wells Fargo's David Maris wants to</a> know how Valeant (VRX <font color='red'>-4%</font>) intends to handle the reporting of a potential settlement.</li><li>\"If a royalty were supposed to be paid and was not, then previous quarters benefitted from the lack of a royalty expense ...&nbsp;If a catch up payment &ndash; a settlement &ndash; were to be made, it may be decided to exclude this from adjusted earnings and adjusted EBITDA as a one-time item, however, it really is to us a previously-deferred expense and should not be excluded.\"</li><li>In other words, says Maris, companies that miss making royalty payments should not benefit from increased earnings in prior periods, and then benefit again by \"playing catchup\" with payments excluded as one-time items from adjusted results.</li><li>Maris continues to rate the stock Underperform with $9 price target.</li></ul><div class=\"tiny-share-widget\" data-id=\"3300994\" data-linked=\"Valeant down 4% as Wells Fargo bear questions accounting\" data-tweet=\"$BHC - Valeant down 4% as Wells Fargo bear questions accounting https://seekingalpha.com/news/3300994-valeant-down-4-wells-fargo-bear-questions-accounting?source=tweet\" data-url=\"https://seekingalpha.com/news/3300994-valeant-down-4-wells-fargo-bear-questions-accounting\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>161&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300990\" data-ts=\"1507915535\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HUBS\" target=\"_blank\">HUBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300990-keybanc-downgrades-hubspot-sharesminus-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KeyBanc downgrades HubSpot; shares -3%</a></h4><ul><li>        KeyBanc downgrades HubSpot (NYSE:<a href='https://seekingalpha.com/symbol/HUBS' title='HubSpot, Inc.'>HUBS</a>) from Overweight to Sector Weight. &nbsp;</li><li>        Analyst Brent Bracelin notes that risk and reward look balanced at the current price and sees few near-term catalysts.</li><li>                  Price target: $102 (bull case), $66 (bear case).    </li><li>               Source: <a href=\"https://thefly.com/landingPageNews.php?id=2622344&amp;headline=HUBS-HubSpot-rating-change-\" target=\"_blank\">The Fly</a>&nbsp;</li><li>               HubSpot shares are&nbsp;<font color='red'>down 2.98%</font>.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3300990\" data-linked=\"KeyBanc downgrades HubSpot; shares -3%\" data-tweet=\"$HUBS - KeyBanc downgrades HubSpot; shares -3% https://seekingalpha.com/news/3300990-keybanc-downgrades-hubspot-sharesminus-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3300990-keybanc-downgrades-hubspot-sharesminus-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300988\" data-ts=\"1507914932\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300988-morgan-stanley-confident-on-pinnacle-foods-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley confident on Pinnacle Foods into earnings</a></h4><ul>     <li>Morgan Stanley weighs in on Pinnacle Foods PF ahead of the company's Q3 earnings report.</li>     <li>\"We view PFas offering arguably the strongest risk-reward in US Food during both Q3 results and 2H17, with upside enhanced by uniquely strong fundamentals and downside limited by the stock's heightened strategic optionality,\" writes Matthew Grainger and team.</li>     <li>\"We view PFas the best positioned within our coverage to successfully manage through the broader industry headwinds depressing results across center-store US Food,\" he adds.</li><li>MS has an Overweight rating and $64 price target on Pinnacle.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3300988\" data-linked=\"Morgan Stanley confident on Pinnacle Foods into earnings\" data-tweet=\"Morgan Stanley confident on Pinnacle Foods into earnings https://seekingalpha.com/news/3300988-morgan-stanley-confident-on-pinnacle-foods-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3300988-morgan-stanley-confident-on-pinnacle-foods-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300986\" data-ts=\"1507914841\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCWX\" target=\"_blank\">SCWX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300986-barclays-downgrades-secureworks-on-key-metrics-sharesminus-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barclays downgrades SecureWorks on key metrics; shares -7%</a></h4><ul><li>        Barclays <a href=\"http://www.briefing.com/DisplayArticle/ArticlePopup.aspx?ArticleId=IN20171013123356SCWX\" target=\"_blank\">downgrades</a> SecureWorks (NASDAQ:<a href='https://seekingalpha.com/symbol/SCWX' title='SecureWorks Corp.'>SCWX</a>) from Equal Weight to Underweight with a $11 price target.</li><li>               The firm cites the loss of SecureWorks&rsquo; sales head, reexamined valuation transition to EV/EBITDA, and weak key metrics like revenue retention despite health in the managed security services market.&nbsp;</li><li>SecureWorks shares are&nbsp;<font color='red'>down 7.06%</font>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3300574-secureworks-chief-revenue-officer\" target=\"_blank\">Secureworks chief revenue officer is out</a> (Oct. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3300986\" data-linked=\"Barclays downgrades SecureWorks on key metrics; shares -7%\" data-tweet=\"$SCWX - Barclays downgrades SecureWorks on key metrics; shares -7% https://seekingalpha.com/news/3300986-barclays-downgrades-secureworks-on-key-metrics-sharesminus-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3300986-barclays-downgrades-secureworks-on-key-metrics-sharesminus-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300984\" data-ts=\"1507914088\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MON\" target=\"_blank\">MON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300984-monsanto-basf-accept-new-restraints-on-dicamba-herbicide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Monsanto, BASF accept new restraints on dicamba herbicide</a></h4><ul>     <li>Monsanto (<a href='https://seekingalpha.com/symbol/MON' title='Monsanto Company'>MON</a> <font color='green'>+2.1%</font>) and BASF (<a href='https://seekingalpha.com/symbol/BASFY' title='BASF SE ADR'>OTCQX:BASFY</a> <font color='red'>-0.1%</font>) have <a href=\"https://www.wsj.com/articles/monsanto-basf-agree-to-new-restraints-on-controversial-herbicide-1507906477\" target=\"_blank\">agreed to new restrictions</a> on the use of the controversial dicamba herbicide that has been blamed for damaging millions of acres of U.S. crops this year.</li>     <li>The EPA approved proposals from the two companies that would make dicamba a &ldquo;restricted use pesticide,&rdquo; meaning the product can be used only by a certified applicator or someone under direct supervision of a certified applicator.</li>     <li>The new limitations on dicamba use fall short of curbs some critics say are necessary to avoid further damage next year, when some projections show spraying of the chemical on U.S. farm fields could double.</li></ul><div class=\"tiny-share-widget\" data-id=\"3300984\" data-linked=\"Monsanto, BASF accept new restraints on dicamba herbicide\" data-tweet=\"$MON $MON $BASFY - Monsanto, BASF accept new restraints on dicamba herbicide https://seekingalpha.com/news/3300984-monsanto-basf-accept-new-restraints-on-dicamba-herbicide?source=tweet\" data-url=\"https://seekingalpha.com/news/3300984-monsanto-basf-accept-new-restraints-on-dicamba-herbicide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300981\" data-ts=\"1507914017\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JBHT\" target=\"_blank\">JBHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300981-trucking-stocks-weak-after-j-b-hunt-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trucking stocks weak after J.B. Hunt earnings</a></h4><ul> <li>Higher expenses led to a Q3 earnings miss for J.B. Transport Services (<a href='https://seekingalpha.com/symbol/JBHT' title='J.B. Hunt Transport Services, Inc.'>JBHT</a> <font color='red'>-3.9%</font>). Baird attributes the weak profit mark to costs associated with J.B. Hunt attracting and retaining drivers (per Bloomberg).</li> <li>As an early reporter, JBHT's earnings are creating a ripple effect across the sector. Decliners include ArcBest (<a href='https://seekingalpha.com/symbol/ARCB' title='ArcBest Corporation'>ARCB</a> <font color='red'>-3.8%</font>), Werner Enterprises (<a href='https://seekingalpha.com/symbol/WERN' title='Werner Enterprises, Inc.'>WERN</a> <font color='red'>-3.2%</font>), Saia (<a href='https://seekingalpha.com/symbol/SAIA' title='Saia, Inc.'>SAIA</a> <font color='red'>-2.3%</font>), YRC Worldwide (<a href='https://seekingalpha.com/symbol/YRCW' title='YRC Worldwide, Inc.'>YRCW</a> <font color='red'>-2.5%</font>) and Heartland Express (<a href='https://seekingalpha.com/symbol/HTLD' title='Heartland Express, Inc.'>HTLD</a> <font color='red'>-1.2%</font>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3300875-j-b-hunt-transport-services-misses-0_05-beats-revenue\" target=\"_blank\">J.B. Hunt Transport Services misses by $0.05, beats on revenue</a> (Oct. 13)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3300882-b-hunt-transport-services-q3\" target=\"_blank\">More on .B. Hunt Transport Services' Q3</a> (Oct. 13)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3300981\" data-linked=\"Trucking stocks weak after J.B. Hunt earnings\" data-tweet=\"$JBHT $JBHT $ARCB - Trucking stocks weak after J.B. Hunt earnings https://seekingalpha.com/news/3300981-trucking-stocks-weak-after-j-b-hunt-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3300981-trucking-stocks-weak-after-j-b-hunt-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300979\" data-ts=\"1507913626\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AERI\" target=\"_blank\">AERI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300979-ad-com-backs-aerie-pharmas-rhopressa-for-lowering-iop-in-patients-glaucoma-and-ocular\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ad Com backs Aerie Pharma&#39;s Rhopressa for lowering IOP in patients with glaucoma and ocular hypertension</a></h4><ul><li>The FDA's Dermatologic and Ophthalmic Drugs Advisory Committee has voted 10-0 that Aerie Pharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/AERI' title='Aerie Pharmaceuticals, Inc.'>AERI</a>) eye drop Rhopressa (netarsudil ophthalmic solution) 0.02% is effective in lowering intraocular pressure in patients with glaucoma or ocular hypertension.</li><li>The vote was 9 -1 that Rhopressa's efficacy outweighs the risks.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3300442-aerie-pharma-breaks-ahead-ad-com-review-rhopressa-lowering-iop-shares-19-percent\" target=\"_blank\">Aerie Pharma breaks out ahead of Ad Com review of Rhopressa for lowering IOP; shares up 19%</a> (Oct. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3300979\" data-linked=\"Ad Com backs Aerie Pharma&#39;s Rhopressa for lowering IOP in patients with glaucoma and ocular hypertension\" data-tweet=\"$AERI - Ad Com backs Aerie Pharma&#39;s Rhopressa for lowering IOP in patients with glaucoma and ocular hypertension https://seekingalpha.com/news/3300979-ad-com-backs-aerie-pharmas-rhopressa-for-lowering-iop-in-patients-glaucoma-and-ocular?source=tweet\" data-url=\"https://seekingalpha.com/news/3300979-ad-com-backs-aerie-pharmas-rhopressa-for-lowering-iop-in-patients-glaucoma-and-ocular\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300978\" data-ts=\"1507913153\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300978-qualcomm-files-suit-to-block-iphone-sales-in-china-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qualcomm files suit to block iPhone sales in China (update)</a></h4><ul><li>Qualcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a>) <a href=\"https://www.bloomberg.com/news/articles/2017-10-13/qualcomm-asks-china-to-halt-manufacture-sale-of-iphones?cmpid=socialflow-twitter-business&amp;utm_content=business&amp;utm_campaign=socialflow-organic&amp;utm_source=twitter&amp;utm_medium=social\" target=\"_blank\">files suit</a> in China seeking to ban the sale and manufacture of Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) iPhones in the region, according to Bloomberg.</li><li>The move is the latest in a long legal battle between the supplier and Apple. Qualcomm previously requested an iPhone ban in the United States.</li><li>Story developing and will update when more information becomes available.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3277356-qualcomm-wants-court-block-iphone-imports-sales\" target=\"_blank\">Qualcomm wants a court to block iPhone imports, sales</a> (July 6)</li><li>        Update: Qualcomm&rsquo;s <a href=\"https://www.bloomberg.com/news/articles/2017-10-13/qualcomm-seeks-china-iphone-ban-escalating-apple-legal-fight\" target=\"_blank\">suits pertain</a> to three non-standard essential patents and the claims were filed in a Beijing court on September 29.</li><li>               Qualcomm says the patents cover power management and a Force Touch technology used in current iPhones.&nbsp;</li><li>                  \"Apple employs technologies invented by Qualcomm without paying for them,\" says Qualcomm spokeswoman Christine Trimble.&nbsp;&nbsp;&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3300978\" data-linked=\"Qualcomm files suit to block iPhone sales in China (update)\" data-tweet=\"$QCOM $QCOM $AAPL - Qualcomm files suit to block iPhone sales in China (update) https://seekingalpha.com/news/3300978-qualcomm-files-suit-to-block-iphone-sales-in-china-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3300978-qualcomm-files-suit-to-block-iphone-sales-in-china-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>135&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300977\" data-ts=\"1507913109\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300977-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LBIX-OLD' title='Leading Brands Inc'>LBIX-OLD</a> <font color='green'>+153%</font>. <a href='https://seekingalpha.com/symbol/NETE' title='Net Element International, Inc.'>NETE</a> <font color='green'>+43%</font>. <a href='https://seekingalpha.com/symbol/CDTI' title='Clean Diesel Technologies, Inc.'>OTC:CDTI</a> <font color='green'>+32%</font>. <a href='https://seekingalpha.com/symbol/MARK' title='Remark Holdings, Inc.'>MARK</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/SOHU' title='Sohu.com Inc.'>SOHU</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/FRSX' title='Foresight Autonomous Holdings Ltd.'>FRSX</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/SPAR' title='Spartan Motors, Inc.'>SPAR</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/ALBO' title='Albireo Pharma, Inc.'>ALBO</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/PN' title='Patriot National, Inc.'>PN</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ATRS' title='Antares Pharma Inc.'>ATRS</a> <font color='red'>-38%</font>. <a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a> <font color='red'>-37%</font>. <a href='https://seekingalpha.com/symbol/RNN' title='Rexahn Pharmaceuticals Inc'>RNN</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/CASI' title='CASI Pharmaceuticals'>CASI</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/MTEM' title='Molecular Templates, Inc.'>MTEM</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/AAOI' title='Applied Optoelectronics, Inc.'>AAOI</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/CLSN' title='Celsion Corporation'>CLSN</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/NEO' title='NeoGenomics Inc.'>NEO</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/AKER' title='Akers Biosciences Inc.'>AKER</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/INFI' title='Infinity Pharmaceuticals, Inc.'>INFI</a> <font color='red'>-16%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3300977\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$LBIX-OLD $NETE $CDTI - Midday Gainers / Losers https://seekingalpha.com/news/3300977-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3300977-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300975\" data-ts=\"1507913098\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNC\" target=\"_blank\">CNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300975-washington-noise-buying-opportunity-for-centene-morgan-stanley\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Washington &quot;noise&quot; a buying opportunity for Centene - Morgan Stanley</a></h4><ul><li>The selloff in Centene (<a href='https://seekingalpha.com/symbol/CNC' title='Centene Corporation'>CNC</a> <font color='red'>-4.5%</font>) from the Trump administration's plan to terminate health insurance subsidies to insurers is \"exaggerated\" according to Morgan Stanley. Shares were down almost&nbsp;<font color='red'>11%</font>&nbsp;before before bargain hunters jumped in.</li><li>In note, analyst Gary Taylor says investors \"misunderstood\" the potential impact from the \"Washington-driven noise,\" citing expected legal challenges that will keep the money flowing and the fact that Centene has submitted two bids in most markets, one assuming cost-sharing reduction &#40;CSR&#41;&nbsp;subsidies and one without, with the ability to change mid-year if CSR funding changes.</li><li>Centene's exchange exposure is only ~8%, with only 60% of those receiving CSRs.</li><li>He also reiterates that most states already asked insurers to load CSR costs into their 2018 bids or submit backup bids if the funding was discontinued.</li><li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3300915-centene-7-percent-premarket-trump-order-end-aca-subsidies\" target=\"_blank\">Centene down 7% premarket on Trump order to end ACA subsidies</a> (Oct. 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3300975\" data-linked=\"Washington &quot;noise&quot; a buying opportunity for Centene - Morgan Stanley\" data-tweet=\"$CNC - Washington &quot;noise&quot; a buying opportunity for Centene - Morgan Stanley https://seekingalpha.com/news/3300975-washington-noise-buying-opportunity-for-centene-morgan-stanley?source=tweet\" data-url=\"https://seekingalpha.com/news/3300975-washington-noise-buying-opportunity-for-centene-morgan-stanley\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300976\" data-ts=\"1507912736\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAOI\" target=\"_blank\">AAOI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300976-needham-lowers-applied-optoelectronics-price-target-sharesminus-19_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham lowers Applied Optoelectronics price target; shares -19.5%</a></h4><ul><li>        Needham <a href=\"http://www.briefing.com/DisplayArticle/ArticlePopup.aspx?ArticleId=IN20171013072636AAOI\" target=\"_blank\">lowers</a> its Applied Optoelectronics (NASDAQ:<a href='https://seekingalpha.com/symbol/AAOI' title='Applied Optoelectronics, Inc.'>AAOI</a>) price target from $115 to $75 following the Q3 preliminary results.</li><li>               Needham notes that revenue was 20% below consensus estimates and Applied Optoelectronics&rsquo; top account dropped 80% to account for just 10% of total sales.&nbsp;</li><li>               The firm says Applied seems to have broadened its customer base and increased 100G sales. Operating expense cuts offset some damage.&nbsp;</li><li>               Craig Hallum also weighs in on the Q3 results with a <a href=\"http://www.briefing.com/DisplayArticle/ArticlePopup.aspx?ArticleId=IN20171013072739AAOI\" target=\"_blank\">downgrade</a> from Buy to Hold.&nbsp;</li><li>                  Applied Optoelectronics shares are&nbsp;<font color='red'>down 19.46%</font>.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3300774-applied-optoelectronics-releases-downbeat-preliminary-q3-results-updated\" target=\"_blank\">Applied Optoelectronics releases downbeat preliminary Q3 results (updated)</a> (Oct. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3300976\" data-linked=\"Needham lowers Applied Optoelectronics price target; shares -19.5%\" data-tweet=\"$AAOI - Needham lowers Applied Optoelectronics price target; shares -19.5% https://seekingalpha.com/news/3300976-needham-lowers-applied-optoelectronics-price-target-sharesminus-19_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3300976-needham-lowers-applied-optoelectronics-price-target-sharesminus-19_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300973\" data-ts=\"1507911859\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLCNF\" target=\"_blank\">GLCNF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300973-wsj-glencore-strikes-standstill-agreement-bunge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WSJ: Glencore strikes standstill agreement with Bunge</a></h4><ul>     <li>Glencore (<a href='https://seekingalpha.com/symbol/GLCNF' title='Glencore Plc'>OTCPK:GLCNF</a>, <a href='https://seekingalpha.com/symbol/GLNCY' title='Glencore Plc ADR'>OTCPK:GLNCY</a>) has a <a href=\"https://www.wsj.com/articles/glencore-strikes-a-standstill-agreement-with-bunge-1507909933\" target=\"_blank\">standstill agreement</a> that temporarily prevents it from making a hostile bid for grains trader Bunge (<a href='https://seekingalpha.com/symbol/BG' title='Bunge Limited'>BG</a> <font color='green'>+7.5%</font>), raising the possibility that it would renew its previous acquisition effort, <em>WSJ</em> reports.</li>     <li>Glencore confirmed <a href=\"https://seekingalpha.com/news/3269387-glencore-confirms-made-takeover-approach-bunge\" target=\"_blank\">in May</a> that it had approached BG about a potential takeover, and investors have since sought clues about whether Glencore and deal-hungry CEO Ivan Glasenberg would follow through on the approach.</li>     <li>The existence of the standstill agreement, which expires early next year, for now prevents Glencore from buying stock in BG but raises the possibility that it could be biding its time before making another approach, according to the report.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3300973\" data-linked=\"WSJ: Glencore strikes standstill agreement with Bunge\" data-tweet=\"$GLCNF $GLCNF $GLNCY - WSJ: Glencore strikes standstill agreement with Bunge https://seekingalpha.com/news/3300973-wsj-glencore-strikes-standstill-agreement-bunge?source=tweet\" data-url=\"https://seekingalpha.com/news/3300973-wsj-glencore-strikes-standstill-agreement-bunge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300972\" data-ts=\"1507911235\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KBSTF\" target=\"_blank\">KBSTF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300972-steel-names-rally-kobe-steel-crisis-deepens\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Steel names rally as Kobe Steel crisis deepens</a></h4><ul>     <li>Shares of <a href=\"http://www.reuters.com/article/us-usa-steel-stocks/u-s-steel-stocks-jump-after-kobe-steel-crisis-deepens-idUSKBN1CI1RW\" target=\"_blank\">steelmakers are on the move</a> after Japan's Kobe Steel (<a href='https://seekingalpha.com/symbol/KBSTF' title='KOBE STEEL LTD ORD NEW'>OTCPK:KBSTF</a>, <a href='https://seekingalpha.com/symbol/KBSTY' title='Kobe Steel, Ltd. ADR'>OTCPK:KBSTY</a>) admitted its data cheating may have spread beyond the country to affect ~500 companies, sparking global supply chain concerns.</li>     <li>\"If you think of any other competitive industry in the commodity business, if one of the major players were knocked out it's looked at as potential for supply disruption which benefits the other players,\" says Wunderlich's Art Hogan.</li>     <li>Also, Chinese finished steel exports in September fell 42% Y/Y to the lowest level since February 2014, which KeyBanc's Philip Gibbs says is encouraging for global supply side dynamics.</li>     <li>And reports suggest the Trump Administration may seek <a href=\"http://uk.reuters.com/article/uk-trade-nafta-steel-exclusive/exclusive-u-s-seeks-to-include-steel-aluminum-in-nafta-autos-rules-sources-idUKKBN1CI1XC\" target=\"_blank\">new automotive content rules</a> as part of  NAFTA negotiations that will require companies to use more North American steel.</li>     <li><a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a> <font color='green'>+9.6%</font>, <a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='green'>+7.5%</font>, <a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='green'>+7.1%</font>, <a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a> <font color='green'>+5.1%</font>, <a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a> <font color='green'>+1.4%</font>, <a href='https://seekingalpha.com/symbol/RS' title='Reliance Steel & Aluminum Co.'>RS</a> <font color='green'>+1.4%</font>, <a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a> <font color='green'>+1.3%</font>, <a href='https://seekingalpha.com/symbol/WOR' title='Worthington Industries, Inc.'>WOR</a> <font color='green'>+1.3%</font>, <a href='https://seekingalpha.com/symbol/CMC' title='Commercial Metals Company'>CMC</a> <font color='green'>+1.2%</font>.</li>     <li>ETF:&nbsp;<a href='https://seekingalpha.com/symbol/SLX' title='VanEck Vectors Steel ETF'>SLX</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3300972\" data-linked=\"Steel names rally as Kobe Steel crisis deepens\" data-tweet=\"$KBSTF $KBSTF $KBSTY - Steel names rally as Kobe Steel crisis deepens https://seekingalpha.com/news/3300972-steel-names-rally-kobe-steel-crisis-deepens?source=tweet\" data-url=\"https://seekingalpha.com/news/3300972-steel-names-rally-kobe-steel-crisis-deepens\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300970\" data-ts=\"1507911038\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSNN\" target=\"_blank\">FSNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300970-fusion-telecom-sharesminus-4_4-on-active-stake-drop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fusion Telecom shares -4.4% on active stake drop</a></h4><ul><li>        Apptix ASA <a href=\"https://www.sec.gov/Archives/edgar/data/1071411/000119312517308999/d474985dsc13da.htm\" target=\"_blank\">lowers its active stake</a> in Fusion Telecom (NASDAQ:<a href='https://seekingalpha.com/symbol/FSNN' title='Fusion Connect, Inc.'>FSNN</a>) to 4.96%, down from 6.54%.</li><li>                  Fusion Telecom shares are&nbsp;<font color='red'>down 4.44%.&nbsp;</font> </li><li>Previously: <a href=\"https://seekingalpha.com/news/3293196-fusion-telecom-minus-5_6-percent-word-insider-sale\" target=\"_blank\">Fusion Telecom -5.6% after word of insider sale</a> (Sept. 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3300970\" data-linked=\"Fusion Telecom shares -4.4% on active stake drop\" data-tweet=\"$FSNN - Fusion Telecom shares -4.4% on active stake drop https://seekingalpha.com/news/3300970-fusion-telecom-sharesminus-4_4-on-active-stake-drop?source=tweet\" data-url=\"https://seekingalpha.com/news/3300970-fusion-telecom-sharesminus-4_4-on-active-stake-drop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300969\" data-ts=\"1507910556\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300969-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LBIX-OLD' title='Leading Brands Inc'>LBIX-OLD</a> <font color='green'>+110%</font>. <a href='https://seekingalpha.com/symbol/SPAR' title='Spartan Motors, Inc.'>SPAR</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/FOSL' title='Fossil, Inc.'>FOSL</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/JAKK' title='JAKKS Pacific, Inc.'>JAKK</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/RFP' title='Resolute Forest Products, Inc.'>RFP</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TWNK' title='Hostess Brands, Inc.'>TWNK</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/WPRT' title='Westport Fuel Systems, Inc.'>WPRT</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/HY' title='Hyster-Yale Materials Handling, Inc.'>HY</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3300969\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$LBIX-OLD $SPAR $FOSL - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3300969-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3300969-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300968\" data-ts=\"1507910520\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MARK\" target=\"_blank\">MARK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300968-remark-holdings-tech-appears-in-weibos-first-ar-app-sharesplus-22\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Remark Holdings&#39; tech appears in Weibo&#39;s first AR app; shares +22%</a></h4><ul><li>        Remark Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/MARK' title='Remark Holdings, Inc.'>MARK</a>) <a href=\"http://ir.remarkholdings.com/releasedetail.cfm?ReleaseID=1043838\" target=\"_blank\">announces</a> that its technology appears in Sina Weibo&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/WB' title='Weibo Corporation'>WB</a>) first AR-enabled mobile app, SuiShouPal.</li><li>               Remark&rsquo;s subsidiary KanKan implemented the app&rsquo;s core AR feature using its 3D facial tracking technology.&nbsp;</li><li>               Remark Holdings shares are&nbsp;<font color='green'>up 22.37%</font>.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3300968\" data-linked=\"Remark Holdings&#39; tech appears in Weibo&#39;s first AR app; shares +22%\" data-tweet=\"$MARK $MARK $WB - Remark Holdings&#39; tech appears in Weibo&#39;s first AR app; shares +22% https://seekingalpha.com/news/3300968-remark-holdings-tech-appears-in-weibos-first-ar-app-sharesplus-22?source=tweet\" data-url=\"https://seekingalpha.com/news/3300968-remark-holdings-tech-appears-in-weibos-first-ar-app-sharesplus-22\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300964\" data-ts=\"1507909232\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADS\" target=\"_blank\">ADS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300964-alliance-data-systems-up-nearly-6-charge-offs-fall\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alliance Data Systems up nearly 6% as charge-offs fall</a></h4><ul><li>In its September update, the company reported net charge-offs as a percent of receivables dipping to 4.1% vs 6.4% a month earlier. For the nine months ended Sept. 30, net charge-offs were 6%.</li><li>Management comments that gross loss rates are tracking slightly better than expectations of about a 50 basis point Y/Y increase for full-year 2017.</li><li>The delinquency rate for September was 5.4% up 40 basis points from one year ago, and slightly worse than management hoped. The hurricanes are likely behind the rise, and it's expected to track back down in Q4.</li><li>Source: <a href=\"https://seekingalpha.com/pr/16967883-b-alliance-b-b-data-b-provides-card-services-performance-update-september-2017\" target=\"_blank\">Press Release</a></li><li><a href='https://seekingalpha.com/symbol/ADS' title='Alliance Data Systems Corporation'>ADS</a>&nbsp;<font color='green'>+5.8%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3300964\" data-linked=\"Alliance Data Systems up nearly 6% as charge-offs fall\" data-tweet=\"$ADS - Alliance Data Systems up nearly 6% as charge-offs fall https://seekingalpha.com/news/3300964-alliance-data-systems-up-nearly-6-charge-offs-fall?source=tweet\" data-url=\"https://seekingalpha.com/news/3300964-alliance-data-systems-up-nearly-6-charge-offs-fall\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300958\" data-ts=\"1507907529\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCG\" target=\"_blank\">PCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300958-pg-and-eminus-7-concerns-grow-over-potential-link-to-california-wildfires\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PG&amp;E -7% as concerns grow over potential link to California wildfires</a></h4><ul>     <li>PG&amp;E (<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a> <font color='red'>-7.6%</font>) shares are suffering their <a href=\"https://www.bloomberg.com/news/articles/2017-10-12/pg-e-falls-on-speculation-downed-power-lines-factor-in-wildfires\" target=\"_blank\">worst week in&nbsp;nine years</a> on <a href=\"https://seekingalpha.com/news/3300754-pg-and-e-plunges-report-links-downed-power-lines-california-fires\" target=\"_blank\">speculatio</a>n that downed power lines may have played a part in deadly wildfires racing across Napa Valley.</li>     <li>The California Public Utilities Commission sent a letter to the utility yesterday seeking to preserve \"all evidence with respect to the  Northern California wildfires in Napa, Sonoma and Solano Counties.\"</li>     <li>California&rsquo;s utility regulator has a history of conducting lengthy proceedings, and investors are bailing out of the stock until more details are available, says Bloomberg's Kit Konolige.</li>     <li>&ldquo;It&rsquo;s a case of shoot first and get answers later,&rdquo; says utility analyst Paul Patterson of Glenrock Associates. &ldquo;It&rsquo;s fear of the unknown potential costs that the company may face.\"</li>     <li>&ldquo;The patience level of California is very short because of the issues PG&amp;E&rsquo;s had before,&rdquo; says Guggenheim analyst Shahriar Pourreza,referring to the deadly 2010 San Bruno gas pipeline explosion and a power line conductor operated by PG&amp;E that ignited a fire in 2015 that burned 70K-plus acres, destroyed hundreds of structures and killed two people.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3300958\" data-linked=\"PG&amp;E -7% as concerns grow over potential link to California wildfires\" data-tweet=\"$PCG - PG&amp;E -7% as concerns grow over potential link to California wildfires https://seekingalpha.com/news/3300958-pg-and-eminus-7-concerns-grow-over-potential-link-to-california-wildfires?source=tweet\" data-url=\"https://seekingalpha.com/news/3300958-pg-and-eminus-7-concerns-grow-over-potential-link-to-california-wildfires\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300954\" data-ts=\"1507907349\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CASI\" target=\"_blank\">CASI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300954-casi-pharma-secures-23m-private-capital-raise-shares-down-21\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CASI Pharma secures $23M private capital raise; shares down 21%</a></h4><ul><li>CASI Pharmaceuticals (<a href='https://seekingalpha.com/symbol/CASI' title='CASI Pharmaceuticals'>CASI</a> <font color='red'>-21.4%</font>) slumps on triple normal volume in response to its <a href=\"https://seekingalpha.com/pr/16968115-casi-pharmaceuticals-announces-23_8-million-registered-direct-offering-led-existing\" target=\"_blank\">agreement</a> with institutional investors for the direct placement of stock and warrants.</li><li>The company has agreed to sell 7,951,868 shares of common stock and accompanying warrants at a combined price of $3.00. Each 2.5-year warrant is eligible to purchase 0.2 of a share of common at $3.75.</li><li>Net proceeds of ~$23.3M will fund the company's business development activities.</li><li>Yesterday's close was $3.64.</li></ul><div class=\"tiny-share-widget\" data-id=\"3300954\" data-linked=\"CASI Pharma secures $23M private capital raise; shares down 21%\" data-tweet=\"$CASI - CASI Pharma secures $23M private capital raise; shares down 21% https://seekingalpha.com/news/3300954-casi-pharma-secures-23m-private-capital-raise-shares-down-21?source=tweet\" data-url=\"https://seekingalpha.com/news/3300954-casi-pharma-secures-23m-private-capital-raise-shares-down-21\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300956\" data-ts=\"1507907002\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300956-sprint-offers-new-deal-on-iphone-8-models\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sprint offers new deal on iPhone 8 models</a></h4><ul><li>        Sprint (NYSE:<a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a>) <a href=\"https://9to5mac.com/2017/10/13/sprint-iphone-8-plus-deal/\" target=\"_blank\">announces</a> new deals for the iPhone 8 and 8 Plus for customers trading in a device and signing up for the Sprint Flex leas program.</li><li>               The 64GB iPhone 8 costs $0 down and has a $9.72 per month Flex payment after a $19.45 per month bill credit.&nbsp;</li><li>               The 256GB IPhone 8 costs $150 down with the same Flex terms.&nbsp;</li><li>               Both iPhone 8 Plus models have a $13.89 per month Flex payment after the bill credit with the 64GB requiring no money down and the 256GB requiring the $150.&nbsp;</li><li>               Sprint held a <a href=\"https://www.statista.com/statistics/199359/market-share-of-wireless-carriers-in-the-us-by-subscriptions/\" target=\"_blank\">12.8% share </a>of the U.S. wireless subscription market in Q2, coming in fourth place.&nbsp;</li><li>                  Analysts predict that initial iPhone 8 sales were weaker than expected, which puts more pressure on carriers to offer attractive deals. &nbsp;&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3298787-rbc-fewer-consumers-want-new-iphones-compared-last-years-models\" target=\"_blank\">RBC: Fewer consumers want new iPhones compared to last year's models</a> (Oct. 2)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3299774-kgi-apples-iphone-super-cycle-coming-2018\" target=\"_blank\">KGI: Apple's iPhone \"super cycle\" coming in 2018</a> (Oct. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3300956\" data-linked=\"Sprint offers new deal on iPhone 8 models\" data-tweet=\"$S - Sprint offers new deal on iPhone 8 models https://seekingalpha.com/news/3300956-sprint-offers-new-deal-on-iphone-8-models?source=tweet\" data-url=\"https://seekingalpha.com/news/3300956-sprint-offers-new-deal-on-iphone-8-models\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300935\" data-ts=\"1507906864\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300935-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/KALV' title='KalVista Pharmaceticals, Inc.'>KALV</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/SBOT' title='Stellar Biotechnologies Inc.'>SBOT</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/ONVO' title='Organovo Holdings, Inc.'>ONVO</a> <font color='green'>+9%</font>. ITEK <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/CUR' title='Neuralstem, Inc.'>CUR</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ATRS' title='Antares Pharma Inc.'>ATRS</a> <font color='red'>-39%</font>. <a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a> <font color='red'>-36%</font>. <a href='https://seekingalpha.com/symbol/RNN' title='Rexahn Pharmaceuticals Inc'>RNN</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/CASI' title='CASI Pharmaceuticals'>CASI</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/AKER' title='Akers Biosciences Inc.'>AKER</a> <font color='red'>-18%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3300935\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$KALV $EDSA $ONVO - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3300935-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3300935-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300949\" data-ts=\"1507905325\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWNK\" target=\"_blank\">TWNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300949-hostess-brands-in-retreat-after-ceo-exit-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hostess Brands in retreat after CEO exit, downgrade</a></h4><ul> <li>Shares of Hostess Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/TWNK' title='Hostess Brands, Inc.'>TWNK</a>) are <font color='red'>down 12%</font> after the company announces the planned departure of its CEO.</li> <li>Sentiment on the food stock wasn't helped by a UBS downgrade to Sell from Neutral. The firm cites slowing trends in key Hostess categories and lowers its view on profit for FY17 and FY18.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3300792-hostess-brands-ceo-steps\" target=\"_blank\">Hostess Brands CEO steps down</a> (Oct. 12)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3300949\" data-linked=\"Hostess Brands in retreat after CEO exit, downgrade\" data-tweet=\"$TWNK - Hostess Brands in retreat after CEO exit, downgrade https://seekingalpha.com/news/3300949-hostess-brands-in-retreat-after-ceo-exit-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3300949-hostess-brands-in-retreat-after-ceo-exit-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300943\" data-ts=\"1507904596\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOVN\" target=\"_blank\">NOVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300943-novan-to-update-investors-october-18-shares-up-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novan to update investors October 18; shares up 4%</a></h4><ul><li>Novan (<a href='https://seekingalpha.com/symbol/NOVN' title='Novan'>NOVN</a> <font color='green'>+4%</font>) will host a <a href=\"https://seekingalpha.com/pr/16967982-novan-announces-corporate-update-conference-call-webcast\" target=\"_blank\">conference call</a> on Wednesday, October 18 at 8:30 am ET to update investors on its activities. The webcast will be archived for seven days on its website.</li><li>Last month, the company announced that the FDA requested a new pivotal study on acne candidate SB204 to support a U.S. marketing application.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3297406-fda-wants-new-clinical-trial-support-lead-candidate-sb204-shares-2-percent\" target=\"_blank\">FDA wants new clinical trial to support lead candidate SB204; shares down 2%</a> (Sept. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3300943\" data-linked=\"Novan to update investors October 18; shares up 4%\" data-tweet=\"$NOVN - Novan to update investors October 18; shares up 4% https://seekingalpha.com/news/3300943-novan-to-update-investors-october-18-shares-up-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3300943-novan-to-update-investors-october-18-shares-up-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300934\" data-ts=\"1507903027\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WFC\" target=\"_blank\">WFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300934-bank-bulls-take-breather-q3-results-roll-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bank bulls take breather as Q3 results roll in</a></h4><ul><li>Bank of America, Wells Fargo, and PNC Financial this morning joined Citigroup and JPMorgan in topping analyst estimates.</li><li>Lest we forget, markets anticipate, and the whole banking group has been on quite the run (up more than 10%) since Labor Day. Investors yesterday and today are selling the news. The major averages are modestly higher, but <a href='https://seekingalpha.com/symbol/KRE' title='SPDR S&P Regional Banking ETF'>KRE</a> and <a href='https://seekingalpha.com/symbol/KBE' title='SPDR S&P Bank ETF'>KBE</a> are each&nbsp;<font color='red'>down more than 1%</font>, and <a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a> is&nbsp;<font color='red'>lower by 0.55%</font>.</li><li>Wells Fargo (<a href='https://seekingalpha.com/symbol/WFC' title='Wells Fargo & Co.'>WFC</a> <font color='red'>-3.4%</font>) is being hit the hardest as investors take note of an unexpected shrinkage in net interest margin. As for reverberations from the account opening scandal, primary consumer checking customers fell 0.2% Y/Y, but total deposits grew 4%. Debit card POS purchase volume rose 5%, and credit card POS purchase volume rose 4%. <a href=\"https://www08.wellsfargomedia.com/assets/pdf/about/investor-relations/earnings/third-quarter-2017-earnings-supplement.pdf\" target=\"_blank\">Q3 quarterly supplement</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3300934\" data-linked=\"Bank bulls take breather as Q3 results roll in\" data-tweet=\"$WFC $KRE $KBE - Bank bulls take breather as Q3 results roll in https://seekingalpha.com/news/3300934-bank-bulls-take-breather-q3-results-roll-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3300934-bank-bulls-take-breather-q3-results-roll-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300929\" data-ts=\"1507902236\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNN\" target=\"_blank\">RNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300929-rexahn-pharma-secures-8m-private-capital-raise-shares-down-24\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rexahn Pharma secures $8M private capital raise; shares down 24%</a></h4><ul><li>Rexahn Pharmaceuticals (<a href='https://seekingalpha.com/symbol/RNN' title='Rexahn Pharmaceuticals Inc'>RNN</a> <font color='red'>-24.3%</font>) inks <a href=\"https://seekingalpha.com/pr/16967999-rexahn-announces-8-million-registered-direct-offering\" target=\"_blank\">agreements </a>with institutional investors for the direct sale of stock and warrants at a unit price of $2.45. Each unit consists of one share of common stock and one warrant to purchase 1/2 of a share of common at $2.85.</li><li>The company expects to raise $8M via the sale of ~3.27M units.</li><li>Yesterday's close was $2.84.</li></ul><div class=\"tiny-share-widget\" data-id=\"3300929\" data-linked=\"Rexahn Pharma secures $8M private capital raise; shares down 24%\" data-tweet=\"$RNN $REXN - Rexahn Pharma secures $8M private capital raise; shares down 24% https://seekingalpha.com/news/3300929-rexahn-pharma-secures-8m-private-capital-raise-shares-down-24?source=tweet\" data-url=\"https://seekingalpha.com/news/3300929-rexahn-pharma-secures-8m-private-capital-raise-shares-down-24\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300928\" data-ts=\"1507902162\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/F\" target=\"_blank\">F</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300928-ford-dips-after-barclays-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ford dips after Barclays cut</a></h4><ul> <li>Ford (NYSE:<a href='https://seekingalpha.com/symbol/F' title='Ford Motor Company'>F</a>) is <font color='red'>down 1.02%</font> after Barclays cuts its rating to Equal-weight from Overweight.</li> <li>Perhaps more painful than the ratings cut itself is the assertion by analyst Brian Johnson that GM is the top electrification and autonomy pick in the sector at the moment.</li> <li>Johnson thinks CEO Jim Hackett is on the right track with Ford's strategy, but thinks the benfits will take a few years to play out.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3300928\" data-linked=\"Ford dips after Barclays cut\" data-tweet=\"$F - Ford dips after Barclays cut https://seekingalpha.com/news/3300928-ford-dips-after-barclays-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3300928-ford-dips-after-barclays-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>57&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300924\" data-ts=\"1507901273\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTX\" target=\"_blank\">BTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300924-biotime-prices-stock-offering-2_60-shares-slip-3-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioTime prices stock offering at $2.60; shares slip 3% premarket</a></h4><ul><li>BioTime (NYSEMKT:<a href='https://seekingalpha.com/symbol/BTX' title='BioTime, Inc'>BTX</a>) is down&nbsp;<font color='red'>3%</font>&nbsp;premarket on average volume in response to the <a href=\"https://seekingalpha.com/pr/16968071-biotime-inc-announces-pricing-25_0-million-public-offering-common-stock\" target=\"_blank\">pricing </a>of its public offering of 9,615,385 shares of common stock at $2.60 per share. Closing date is October 17.</li><li>Yesterday's close was $2.73.</li></ul><div class=\"tiny-share-widget\" data-id=\"3300924\" data-linked=\"BioTime prices stock offering at $2.60; shares slip 3% premarket\" data-tweet=\"$BTX $LCTX - BioTime prices stock offering at $2.60; shares slip 3% premarket https://seekingalpha.com/news/3300924-biotime-prices-stock-offering-2_60-shares-slip-3-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3300924-biotime-prices-stock-offering-2_60-shares-slip-3-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300923\" data-ts=\"1507901258\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300923-facebook-rolls-out-food-ordering-through-website\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook rolls out food ordering through its website</a></h4><ul><li>           Facebook (NASDAQ:<a href='https://seekingalpha.com/symbol/FB' title='Facebook'>FB</a>) is <a href=\"https://www.theverge.com/2017/10/13/16468610/facebook-food-ordering-new-feature\" target=\"_blank\">rolling out</a> the ability to order food straight through its website. </li><li> The feature will incorporate several food ordering services including Delivery.com, EatStreet, and ChowNow. </li><li> Customers can order take-out or delivery from restaurants including Jack in the Box, Panera, and Five Guys. </li><li> Facebook began testing the feature last year but is now ready for a wide U.S. release on iOS, Android, and desktop. </li><li> Facebook shares are&nbsp;<font color='green'>up 0.46%</font>&nbsp;premarket. </li><li>           GrubHub (NYSE:<a href='https://seekingalpha.com/symbol/GRUB' title='GrubHub Inc.'>GRUB</a>) shares are&nbsp;<font color='red'>down 2.99%</font>&nbsp;premarket due to the new competition. &nbsp;<br />&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3300923\" data-linked=\"Facebook rolls out food ordering through its website\" data-tweet=\"$FB $FB $GRUB - Facebook rolls out food ordering through its website https://seekingalpha.com/news/3300923-facebook-rolls-out-food-ordering-through-website?source=tweet\" data-url=\"https://seekingalpha.com/news/3300923-facebook-rolls-out-food-ordering-through-website\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300922\" data-ts=\"1507901029\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300922-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/ATRS' title='Antares Pharma Inc.'>ATRS</a>&nbsp;<font color='red'>-42%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3300817-antares-pharma-minus-30-percent-fda-finds-deficiencies-xyosted-nda\" target=\"_blank\">providing</a> XYOSTED regulatory update.</li><li><a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a>&nbsp;<font color='red'>-32%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3300777-tandem-diabetes-care-readies-equity-offering-shares-23-percent-hours\" target=\"_blank\">announcing</a> proposed public offering of common stock.</li><li><a href='https://seekingalpha.com/symbol/AAOI' title='Applied Optoelectronics, Inc.'>AAOI</a>&nbsp;<font color='red'>-20%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3300774-applied-optoelectronics-releases-downbeat-preliminary-q3-results-updated\" target=\"_blank\">announcing</a> Q3 preliminary results.</li><li><a href='https://seekingalpha.com/symbol/RNN' title='Rexahn Pharmaceuticals Inc'>RNN</a> <font color='red'>-17%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16967999-rexahn-announces-8-million-registered-direct-offering\" target=\"_blank\">announcing</a> $8M registered direct offering.</li><li><a href='https://seekingalpha.com/symbol/CYH' title='Community Health Systems, Inc.'>CYH</a>&nbsp;<font color='red'>-10%</font>&nbsp;on Trump's plan to&nbsp;end health insurance <a href=\"https://seekingalpha.com/news/3300906-trumps-plan-end-health-insurance-subsidies-bearish-hospitals-mizuho\" target=\"_blank\">subsidies</a> bearish for hospitals.</li><li><a href='https://seekingalpha.com/symbol/ECYT' title='Endocyte, Inc.'>ECYT</a>&nbsp;<font color='red'>-9%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3300808-endocyte-registers-150m-mixed-shelf-offering-shares-slip-2-percent-hours\" target=\"_blank\">registering</a> $150M mixed shelf offering</li><li><a href='https://seekingalpha.com/symbol/INFI' title='Infinity Pharmaceuticals, Inc.'>INFI</a>&nbsp;<font color='red'>-8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3300762-infinity-pharma-big-news-scarce-shares-ahead-90-percent\" target=\"_blank\">announcing</a> IPI-549 late-breaking presentation at SITC Annual Meeting.</li><li><a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a>&nbsp;<font color='red'>-8%</font>&nbsp;on Trump's plan to&nbsp;end health insurance&nbsp;<a href=\"https://seekingalpha.com/news/3300918-health-stocks-face-day-trump-order-end-subsidies-aca-insurers\" target=\"_blank\">subsidies</a>&nbsp;bearish for hospitals.</li><li><a href='https://seekingalpha.com/symbol/CNC' title='Centene Corporation'>CNC</a>&nbsp;<font color='red'>-7%</font>&nbsp;on Trump's plan to&nbsp;end health insurance&nbsp;<a href=\"https://seekingalpha.com/news/3300915-centene-7-percent-premarket-trump-order-end-aca-subsidies\" target=\"_blank\">subsidies</a>&nbsp;bearish for hospitals.</li><li><a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a>&nbsp;<font color='red'>-7%</font>&nbsp;after catching the anticipated negative price action.</li><li><a href='https://seekingalpha.com/symbol/DDD' title='3D Systems Corp.'>DDD</a> <font color='red'>-6%</font>.</li><li><a href='https://seekingalpha.com/symbol/HCA' title='HCA Holdings, Inc.'>HCA</a>&nbsp;<font color='red'>-5%</font>&nbsp;on Trump's plan to&nbsp;end health insurance&nbsp;<a href=\"https://seekingalpha.com/news/3300918-health-stocks-face-day-trump-order-end-subsidies-aca-insurers\" target=\"_blank\">subsidies</a>&nbsp;bearish for hospitals.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3300922\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$ATRS $TNDM $AAOI - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3300922-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3300922-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300921\" data-ts=\"1507901008\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNDM\" target=\"_blank\">TNDM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300921-tandem-diabetes-care-prices-equity-offering-shares-down-31-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tandem Diabetes Care prices equity offering; shares down 31% premarket</a></h4><ul><li>Tandem Diabetes Care (NASDAQ:<a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a>) is down&nbsp;<font color='red'>31%</font>&nbsp;premarket on increased volume in response to the <a href=\"https://seekingalpha.com/pr/16968064-tandem-diabetes-care-announces-pricing-16_2-million-underwritten-public-offering-common-stock\" target=\"_blank\">pricing </a>of public equity offering.</li><li>The company is offering 4.63M shares of common stock, Series A warrants to purchase up to 4.63M shares of common and Series B warrants to purchase up to 4.63M shares of common at a combined price of $3.50.</li><li>The five-year Series A warrants are immediately exercisable at $3.50. The six-month Series B warrants are also immediately exercisable at $3.50.</li><li>Net proceeds will be used for general corporate purposes. Closing date is October 17.</li></ul><div class=\"tiny-share-widget\" data-id=\"3300921\" data-linked=\"Tandem Diabetes Care prices equity offering; shares down 31% premarket\" data-tweet=\"$TNDM - Tandem Diabetes Care prices equity offering; shares down 31% premarket https://seekingalpha.com/news/3300921-tandem-diabetes-care-prices-equity-offering-shares-down-31-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3300921-tandem-diabetes-care-prices-equity-offering-shares-down-31-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300920\" data-ts=\"1507900979\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AA\" target=\"_blank\">AA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300920-alcoa-secures-early-termination-of-power-contract-tied-to-rockdale-smelter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alcoa secures early termination of power contract tied to Rockdale smelter</a></h4><ul>     <li>Alcoa (NYSE:<a href='https://seekingalpha.com/symbol/AA' title='Alcoa Corporation'>AA</a>)&nbsp;<font color='green'>+2.4%</font>&nbsp;premarket after saying it reached agreement for the <a href=\"https://seekingalpha.com/pr/16967894-alcoa-corporation-reaches-early-termination-agreement-power-contract-tied-curtailed-rockdale\" target=\"_blank\">early termination</a> of a power contract with Vistra Energy (NYSE:<a href='https://seekingalpha.com/symbol/VST' title='Vistra Energy Corp.'>VST</a>) subsidiary Luminant tied to its Rockdale smelter in Texas.</li>     <li>While Alcoa has been selling surplus electricity since the smelter was curtailed at year-end 2008, the company says its cost of power under the contract exceeded the related revenue; the contract originally was intended to expire no later than 2038.</li><li>Alcoa says it expects annual net income to be increased by $60M-$70M as a result of the early termination, and says it will book a one-time ~$250M charge in Q4 because of the deal.</li><li>Alcoa also has initiated a strategic       review of the remaining buildings and equipment associated with the       smelter, and expects to make a decision on the       assets by year-end 2017.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3300920\" data-linked=\"Alcoa secures early termination of power contract tied to Rockdale smelter\" data-tweet=\"$AA $AA $VST - Alcoa secures early termination of power contract tied to Rockdale smelter https://seekingalpha.com/news/3300920-alcoa-secures-early-termination-of-power-contract-tied-to-rockdale-smelter?source=tweet\" data-url=\"https://seekingalpha.com/news/3300920-alcoa-secures-early-termination-of-power-contract-tied-to-rockdale-smelter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300919\" data-ts=\"1507900677\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300919-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/MARK' title='Remark Holdings, Inc.'>MARK</a> <font color='green'>+39%</font>.</li>     <li>ITEK <font color='green'>+23%</font>&nbsp;on proxy statement for <a href=\"https://seekingalpha.com/news/3300911-inotek-files-proxy-statement-proposed-merger-rocket-pharmaceuticals-shares-ahead-21-percent\" target=\"_blank\">proposed merger</a> with Rocket. Pharmaceuticals.</li>     <li><a href='https://seekingalpha.com/symbol/MGEN' title='Miragen Therapeutics, Inc.'>MGEN</a> <font color='green'>+11%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3300890-miragen-therapeutics-presents-new-clinical-data-mrgminus-106-mycosis-fungoides-shares-ahead\" target=\"_blank\">new clinical data</a> from MRG-106 on mycosis fungoides.</li>     <li><a href='https://seekingalpha.com/symbol/AKER' title='Akers Biosciences Inc.'>AKER</a> <font color='green'>+9%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/NLNK' title='NewLink Genetics Corporation'>NLNK</a> <font color='green'>+8%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/CPST' title='Capstone Turbine Corporation'>CPST</a> <font color='green'>+6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/ONCE' title='Spark Therapeutics'>ONCE</a> <font color='green'>+6%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/news/3300815-spark-therapeutics-resumes-trading-6_4-percent\" target=\"_blank\">unanimous FDA advisory committee vote</a>&nbsp;in favor of approving the company's treatment for mutation-associated retinal dystrophy.</li>     <li><a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='green'>+6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a> <font color='green'>+5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3300919\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$MARK $RCKT $MGEN - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3300919-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3300919-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300918\" data-ts=\"1507900427\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYH\" target=\"_blank\">CYH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300918-health-stocks-face-down-day-on-trump-order-to-end-subsidies-for-aca-insurers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Health stocks face a down day on Trump order to end subsidies for ACA insurers</a></h4><ul><li>Hospital operators (and others) are set for a down day on the risk to earnings after President Trump's executive order that will end Obamacare subsidies to health insurers next year.</li><li>Premarket: <a href='https://seekingalpha.com/symbol/CYH' title='Community Health Systems, Inc.'>CYH</a>&nbsp;<font color='red'>-10%</font>; <a href='https://seekingalpha.com/symbol/LPNT' title='LifePoint Health, Inc.'>LPNT</a>&nbsp;<font color='red'>-5%</font>; <a href='https://seekingalpha.com/symbol/HCA' title='HCA Holdings, Inc.'>HCA</a>&nbsp;<font color='red'>-5%;</font>&nbsp;<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a> (unch); <a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a>&nbsp;<font color='red'>-9%</font>; <a href='https://seekingalpha.com/symbol/AET' title='Aetna, Inc.'>AET</a>&nbsp;<font color='red'>-1%</font>; <a href='https://seekingalpha.com/symbol/MOH' title='Molina Healthcare, Inc.'>MOH</a>&nbsp;<font color='red'>-3%;</font>&nbsp;<a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Inc.'>UNH</a>&nbsp;<font color='red'>-1%.</font></li><li>Previously: <a href=\"https://seekingalpha.com/news/3300906-trumps-plan-end-health-insurance-subsidies-bearish-hospitals-mizuho\" target=\"_blank\">Trump's plan to end health insurance subsidies bearish for hospitals - Mizuho</a> (Oct. 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3300918\" data-linked=\"Health stocks face a down day on Trump order to end subsidies for ACA insurers\" data-tweet=\"$CYH $CYH $LPNT - Health stocks face a down day on Trump order to end subsidies for ACA insurers https://seekingalpha.com/news/3300918-health-stocks-face-down-day-on-trump-order-to-end-subsidies-for-aca-insurers?source=tweet\" data-url=\"https://seekingalpha.com/news/3300918-health-stocks-face-down-day-on-trump-order-to-end-subsidies-for-aca-insurers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300917\" data-ts=\"1507899996\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300917-netflix-up-after-price-target-increase-to-new-street-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Netflix up after price target increase to new Street high</a></h4><ul><li>        Netflix (NASDAQ:<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>) shares are&nbsp;<font color='green'>up 1.6%</font>&nbsp;premarket after <a href=\"https://www.cnbc.com/2017/10/13/netflix-gets-its-most-bullish-wall-street-call-yet-from-goldman-sachs.html\" target=\"_blank\">price target increases</a> at JPMorgan and Goldman Sachs.</li><li>               JPMorgan raises Netflix from $210 to $225.&nbsp;</li><li>               Goldman Sachs raises its price target by $35 to $235, which marks a new Street high.&nbsp;</li><li>               Analyst Heath Terry thinks the market has underestimated Netflix subscriber numbers for the current quarter &ldquo;and beyond.&rdquo;&nbsp;</li><li>               Terry expects Netflix to add 13.9M net subscribers in 2H of 2017 compared to the 10.8M consensus.&nbsp;</li><li>                  Netflix reports Q3 results on October 16.&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3300660-teenagers-pick-favorite-brands\" target=\"_blank\">Teenagers pick their favorite brands</a> (Oct. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3300917\" data-linked=\"Netflix up after price target increase to new Street high\" data-tweet=\"$NFLX - Netflix up after price target increase to new Street high https://seekingalpha.com/news/3300917-netflix-up-after-price-target-increase-to-new-street-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3300917-netflix-up-after-price-target-increase-to-new-street-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300915\" data-ts=\"1507899801\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNC\" target=\"_blank\">CNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300915-centene-down-7-premarket-on-trump-order-to-end-aca-subsidies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Centene down 7% premarket on Trump order to end ACA subsidies</a></h4><ul><li>Centene (NYSE:<a href='https://seekingalpha.com/symbol/CNC' title='Centene Corporation'>CNC</a>) is down&nbsp;<font color='red'>7%</font>&nbsp;premarket on light volume on the heels of President Trump's executive order that will end subsidies for Obamacare health insurers next year, a segment that contributes ~15% of its earnings.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3300906-trumps-plan-end-health-insurance-subsidies-bearish-hospitals-mizuho\" target=\"_blank\">Trump's plan to end health insurance subsidies bearish for hospitals - Mizuho</a> (Oct. 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3300915\" data-linked=\"Centene down 7% premarket on Trump order to end ACA subsidies\" data-tweet=\"$CNC - Centene down 7% premarket on Trump order to end ACA subsidies https://seekingalpha.com/news/3300915-centene-down-7-premarket-on-trump-order-to-end-aca-subsidies?source=tweet\" data-url=\"https://seekingalpha.com/news/3300915-centene-down-7-premarket-on-trump-order-to-end-aca-subsidies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300912\" data-ts=\"1507899553\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TOPS\" target=\"_blank\">TOPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300912-top-shipsplus-50-completes-kalani-purchase-agreement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Top Ships +50% as it completes Kalani purchase agreement</a></h4><ul>     <li>Top Ships (NASDAQ:<a href='https://seekingalpha.com/symbol/TOPS' title='TOP Ships Inc.'>TOPS</a>) <font color='green'>+49.2%</font> premarket after disclosing the <a href=\"https://seekingalpha.com/filing/3726822\" target=\"_blank\">completion of its purchase agreement</a> with Kalani Investments and that remaining contractual commitments for the acquisition of its newbuilding fleet total $30.7M.</li>     <li>TOPS also says it received notification from Nasdaq that its stock price had <a href=\"https://seekingalpha.com/pr/16967635-top-ships-inc-announces-receipt-nasdaq-notice\" target=\"_blank\">remained below $1/share</a> for the last 30  consecutive business days and no  longer meets the minimum bid price requirement.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3300912\" data-linked=\"Top Ships +50% as it completes Kalani purchase agreement\" data-tweet=\"$TOPS - Top Ships +50% as it completes Kalani purchase agreement https://seekingalpha.com/news/3300912-top-shipsplus-50-completes-kalani-purchase-agreement?source=tweet\" data-url=\"https://seekingalpha.com/news/3300912-top-shipsplus-50-completes-kalani-purchase-agreement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300911\" data-ts=\"1507899364\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RCKT\" target=\"_blank\">RCKT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300911-inotek-files-proxy-statement-for-proposed-merger-rocket-pharmaceuticals-shares-ahead-21\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inotek files proxy statement for proposed merger with Rocket Pharmaceuticals; shares ahead 21% premarket</a></h4><ul><li>inotek Pharmaceuticals (ITEK) is up&nbsp;<font color='green'>21%</font>&nbsp;premarket on robust volume in response to its <a href=\"https://seekingalpha.com/pr/16967697-inotek-pharmaceuticals-announces-filing-preliminary-proxy-statement-proposed-merger-clinical\" target=\"_blank\">filing </a>of a preliminary <a href=\"https://www.sec.gov/Archives/edgar/data/1281895/000119312517308897/d407163dprem14a.htm\" target=\"_blank\">proxy statement</a> related to its previously announced planned merger with gene therapy outfit Rocket Pharmaceuticals.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3294978-inotek-pharma-merge-gene-therapy-developer-rocket-pharmaceuticals\" target=\"_blank\">Inotek Pharma to merge with gene therapy developer Rocket Pharmaceuticals</a> (Sept. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3300911\" data-linked=\"Inotek files proxy statement for proposed merger with Rocket Pharmaceuticals; shares ahead 21% premarket\" data-tweet=\"$RCKT - Inotek files proxy statement for proposed merger with Rocket Pharmaceuticals; shares ahead 21% premarket https://seekingalpha.com/news/3300911-inotek-files-proxy-statement-for-proposed-merger-rocket-pharmaceuticals-shares-ahead-21?source=tweet\" data-url=\"https://seekingalpha.com/news/3300911-inotek-files-proxy-statement-for-proposed-merger-rocket-pharmaceuticals-shares-ahead-21\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300909\" data-ts=\"1507899033\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300909-needham-ups-nvidia-price-target-on-data-center-potential\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham ups Nvidia price target on data center potential</a></h4><ul><li>        Needham <a href=\"http://www.briefing.com/DisplayArticle/ArticlePopup.aspx?ArticleId=IN20171013080858NVDA\" target=\"_blank\">raises</a> its Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) price target by $50 to $250.</li><li>               The increase follows conversations with CEO Jensen Huang at the GTC conference that made the firm optimistic about Nvidia&rsquo;s data center potential.&nbsp;</li><li>                  Needham estimates that the data center TAM could total between $21B and $35B in the next five years, though it could take several years for Nvidia to capture the market.    </li><li>                  The firm thinks some of this growth potential is already priced in but argues that Nvidia deserves a higher multiple.    </li><li>               Nvidia shares are&nbsp;<font color='green'>up 1.06%</font>&nbsp;premarket.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3300909\" data-linked=\"Needham ups Nvidia price target on data center potential\" data-tweet=\"$NVDA - Needham ups Nvidia price target on data center potential https://seekingalpha.com/news/3300909-needham-ups-nvidia-price-target-on-data-center-potential?source=tweet\" data-url=\"https://seekingalpha.com/news/3300909-needham-ups-nvidia-price-target-on-data-center-potential\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>71&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300906\" data-ts=\"1507898886\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HCA\" target=\"_blank\">HCA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300906-trumps-plan-to-end-health-insurance-subsidies-bearish-for-hospitals-mizuho\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trump&#39;s plan to end health insurance subsidies bearish for hospitals - Mizuho</a></h4><ul><li>Mizuho's Sheryl Skolnick says the Trump administration's plan to end cost-sharing subsidies to health insurers will weigh on hospital operators saying Q4 and 2018 estimates are \"likely too high\" adding, \"the effect of the order is likely to be profoundly destabilizing, disruptive and potentially materially damaging to hospitals and those exchange plans who are still required to offer benefits.\"</li><li>She says the change could motivate (NYSE:<a href='https://seekingalpha.com/symbol/HCA' title='HCA Holdings, Inc.'>HCA</a>), the largest publicly traded hospital chain in the U.S., to go private while further tarnishing the credit quality of operators like Tenet Healthcare (NYSE:<a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a>), Community Health Systems (NYSE:<a href='https://seekingalpha.com/symbol/CYH' title='Community Health Systems, Inc.'>CYH</a>) and Quorum Health (NYSE:<a href='https://seekingalpha.com/symbol/QHC' title='Quorum Health Corporation'>QHC</a>).</li><li>Evercore ISI's Michael Newshel says Trump's executive order is \"likely not the final word\" on the issue since bipartisan talks to appropriate funds will probably be pushed forward and lawsuits should keep the money flowing. He also believes the move Is a \"blow the market could ultimately absorb\" since insurers have been exiting the market and have assumed the end of subsidies in their 2018 rate hikes.</li><li>Leerink's Ana Gupte says the order is most bearish for Centene (NYSE:<a href='https://seekingalpha.com/symbol/CNC' title='Centene Corporation'>CNC</a>) considering that ~15% of its earnings are through Obamacare exchanges.</li><li>Source: Bloomberg</li><li>Selected tickers: <a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a> <a href='https://seekingalpha.com/symbol/AET' title='Aetna, Inc.'>AET</a> <a href='https://seekingalpha.com/symbol/CI' title='Cigna Corporation'>CI</a> <a href='https://seekingalpha.com/symbol/MOH' title='Molina Healthcare, Inc.'>MOH</a> <a href='https://seekingalpha.com/symbol/LPNT' title='LifePoint Health, Inc.'>LPNT</a> <a href='https://seekingalpha.com/symbol/HQY' title='HealthEquity'>HQY</a> <a href='https://seekingalpha.com/symbol/UHS' title='Universal Health Services Inc.'>UHS</a> <a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Inc.'>UNH</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3300906\" data-linked=\"Trump&#39;s plan to end health insurance subsidies bearish for hospitals - Mizuho\" data-tweet=\"$HCA $HCA $THC - Trump&#39;s plan to end health insurance subsidies bearish for hospitals - Mizuho https://seekingalpha.com/news/3300906-trumps-plan-to-end-health-insurance-subsidies-bearish-for-hospitals-mizuho?source=tweet\" data-url=\"https://seekingalpha.com/news/3300906-trumps-plan-to-end-health-insurance-subsidies-bearish-for-hospitals-mizuho\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>47&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300890\" data-ts=\"1507897526\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGEN\" target=\"_blank\">MGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300890-miragen-therapeutics-presents-new-clinical-data-from-mrgminus-106-on-mycosis-fungoides-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">miRagen Therapeutics presents new clinical data from MRG-106 on mycosis fungoides; shares ahead 11% premarket</a></h4><ul> <li>miRagen Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MGEN' title='Miragen Therapeutics, Inc.'>MGEN</a>) <a href=\"https://seekingalpha.com/pr/16967865-miragen-therapeutics-presents-new-clinical-data-suggesting-positive-impact-systemically\" target=\"_blank\">announces</a> new interim results from its ongoing Phase 1 clinical trial evaluating the safety, efficacy and pharmacokinetics of <a href=\"http://www.miragen.com/clinical-trials/\" target=\"_blank\">MRG-106</a> in patients with the <a href=\"https://en.wikipedia.org/wiki/Mycosis_fungoides\" target=\"_blank\">mycosis fungoides</a> form of cutaneous T-cell lymphoma &#40;CTCL&#41;. The data are being presented at the European Organisation for Research and Treatment of Cancer Cutaneous Lymphoma Task Force Meeting in London.</li>       <li>The study consists of two parts. In the first, patients were treated with 75 mg injections of MRG-106 directly into a specific lesion. The second employed a multiple dose-escalation design with subcutaneous or intravenous administrations of MRG-106. Interim data from the second part of the Phase 1 trial are summarized below:</li><li>96% (n=22/23)&nbsp;of patients treated systemically experienced improvement in total skin disease at all dose levels evaluated as measured by a scale called mSWAT. The magnitude of mSWAT improvements appeared to correlate with the time on treatment.</li><li>MRG-106 has been generally well-tolerated for all 27 patients evaluated to date at dose levels ranging from 75 mg to 900 mg. Injection site reactions were observed in some patients (subcutaneous). One patient experienced a Grade 3 (serious) adverse event (worsening of itchy skin) that was potentially related to MRG-106.</li>  <li>MRG-106 is an inhibitor of microRNA-155. In CTCL, as well as certain other blood cancers, microRNA-155 is present at abnormally high levels, and may play a role in the proliferation of blood and lymph cells.</li><li>The company plans to evaluate it in other blood cancers.</li><li>Shares are up&nbsp;<font color='green'>11%</font>&nbsp;premarket on light volume.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3300890\" data-linked=\"miRagen Therapeutics presents new clinical data from MRG-106 on mycosis fungoides; shares ahead 11% premarket\" data-tweet=\"$MGEN - miRagen Therapeutics presents new clinical data from MRG-106 on mycosis fungoides; shares ahead 11% premarket https://seekingalpha.com/news/3300890-miragen-therapeutics-presents-new-clinical-data-from-mrgminus-106-on-mycosis-fungoides-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3300890-miragen-therapeutics-presents-new-clinical-data-from-mrgminus-106-on-mycosis-fungoides-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300894\" data-ts=\"1507896402\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHP\" target=\"_blank\">BHP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300894-iron-ore-rallies-chinas-clean-air-push-hurts-local-supply\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Iron ore rallies as China&#39;s clean air push hurts local supply</a></h4><ul>     <li><a href=\"https://www.bloomberg.com/news/articles/2017-10-13/iron-imports-by-china-smash-100-million-ton-level-to-hit-record\" target=\"_blank\">Iron ore prices rally</a> as imports by China surged above 100M metric tons to a new record high, as the country&rsquo;s drive to clean up the environment sparked demand for higher-grade material from overseas while curbing local supply.</li>     <li>Iron ore purchases jumped 10.5% in September to 102.8M tons from 93M tons a year ago, surpassing the previous record of 96.3M tons in December 2015, according to the latest customs; YTD through the end of September, imports rose 7% to 817M tons, putting full-year purchases on track to easily exceed 1B tons.</li>     <li>The benchmark spot price for 62% content ore in Qingdao jumped 4.1% today, the most since August, to $62.53/dry ton.</li>     <li>In premarket trading: <a href='https://seekingalpha.com/symbol/BHP' title='BHP Billiton Limited'>BHP</a> <font color='green'>+2%</font>, <a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto plc'>RIO</a> <font color='green'>+2.3%</font>, <a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color='green'>+3.4%</font>.</li>     <li>Other relevant tickers include <a href='https://seekingalpha.com/symbol/FSUMF' title='Fortescue Metals Group Ltd'>OTCQX:FSUMF</a>, <a href='https://seekingalpha.com/symbol/AAUKF' title='Anglo American plc'>OTCQX:AAUKF</a>, <a href='https://seekingalpha.com/symbol/AAUKY' title='Anglo American plc ADR'>OTCPK:AAUKY</a>, <a href='https://seekingalpha.com/symbol/GLCNF' title='Glencore Plc'>OTCPK:GLCNF</a>, <a href='https://seekingalpha.com/symbol/GLNCY' title='Glencore Plc ADR'>OTCPK:GLNCY</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3300894\" data-linked=\"Iron ore rallies as China&#39;s clean air push hurts local supply\" data-tweet=\"$BHP $BHP $RIO - Iron ore rallies as China&#39;s clean air push hurts local supply https://seekingalpha.com/news/3300894-iron-ore-rallies-chinas-clean-air-push-hurts-local-supply?source=tweet\" data-url=\"https://seekingalpha.com/news/3300894-iron-ore-rallies-chinas-clean-air-push-hurts-local-supply\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300885\" data-ts=\"1507895467\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNDM\" target=\"_blank\">TNDM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300885-tandem-diabetes-care-sees-27m-in-q3-sales-shares-down-30-premarket-on-proposed-equity\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tandem Diabetes Care sees ~$27M in Q3 sales; shares down 30% premarket on proposed equity offering</a></h4><ul><li>On a <a href=\"https://www.sec.gov/Archives/edgar/data/1438133/000156459017019447/tndm-8k_20171012.htm\" target=\"_blank\">preliminary basis</a>, Tandem Diabetes Care (NASDAQ:<a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a>) expects $26.5M - 27.5M in revenue in Q3, consistent with consensus view of $26.1M. It shipped 3,868 pumps during the quarter.</li><li>The company cites the adverse impact on sales from recent hurricanes, but does not provide the specific financial ramifications.</li><li>Shares are down&nbsp;<font color='red'>30%</font>&nbsp;premarket in response to its planned equity offering.</li></ul><div class=\"tiny-share-widget\" data-id=\"3300885\" data-linked=\"Tandem Diabetes Care sees ~$27M in Q3 sales; shares down 30% premarket on proposed equity offering\" data-tweet=\"$TNDM - Tandem Diabetes Care sees ~$27M in Q3 sales; shares down 30% premarket on proposed equity offering https://seekingalpha.com/news/3300885-tandem-diabetes-care-sees-27m-in-q3-sales-shares-down-30-premarket-on-proposed-equity?source=tweet\" data-url=\"https://seekingalpha.com/news/3300885-tandem-diabetes-care-sees-27m-in-q3-sales-shares-down-30-premarket-on-proposed-equity\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300882\" data-ts=\"1507895076\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JBHT\" target=\"_blank\">JBHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300882-on-b-hunt-transport-services-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on .B. Hunt Transport Services&#39; Q3</a></h4><ul><li>J.B. Hunt Transport Services (NASDAQ:<a href='https://seekingalpha.com/symbol/JBHT' title='J.B. Hunt Transport Services, Inc.'>JBHT</a>)&nbsp;reports total operating revenue (excl. fuel surcharges) rose 7.7% to $1.66B in <a href=\"https://seekingalpha.com/pr/16967878-j-b-hunt-transport-services-inc-reports-earnings-third-quarter-2017\" target=\"_blank\">Q3</a>.</li><li>Segment revenue:&nbsp;Intermodal: $1.05B (+8%);&nbsp;Dedicated&nbsp;Contract Services: $438M&nbsp;(+11%);&nbsp;Integrated Capacity Solutions: $269M (+16%); Truck: $93M (-5%).</li><li>Segment income:&nbsp;Intermodal: $109.1M (-7%);&nbsp;Dedicated: $42.9M (-18%);&nbsp;Integrated Capacity Solutions: $7.3M (-14%); Truck: $5.7M (+12%).</li><li>Operating margin rate squeezed 190 bps to 8.9%.</li><li>Total tractors in operation -143 Y/Y to 2,040</li><li>Total trailers in operation -34 Y/Y to 7,538.</li><li>The company expects effective tax rate of ~35% in FY2017.</li></ul><div class=\"tiny-share-widget\" data-id=\"3300882\" data-linked=\"More on .B. Hunt Transport Services&#39; Q3\" data-tweet=\"$JBHT - More on .B. Hunt Transport Services&#39; Q3 https://seekingalpha.com/news/3300882-on-b-hunt-transport-services-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3300882-on-b-hunt-transport-services-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300881\" data-ts=\"1507894967\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETH\" target=\"_blank\">ETH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300881-dougherty-buys-dip-in-ethan-allen\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dougherty buys the dip in Ethan Allen</a></h4><ul> <li>Dougherty &amp; Company upgrades Ethan Allen (NYSE:<a href='https://seekingalpha.com/symbol/ETH' title='Ethan Allen Interiors Inc.'>ETH</a>) to a Buy rating on a valuation call after having the retailer set at Neutral.</li> <li>Ethan Allen fell 4.9% yesterday after the company slashed FQ1 EPS guidance due in part to the impact of the U.S. hurricanes. Shares of Ethan Allen are down 21% YTD.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3300881\" data-linked=\"Dougherty buys the dip in Ethan Allen\" data-tweet=\"$ETH - Dougherty buys the dip in Ethan Allen https://seekingalpha.com/news/3300881-dougherty-buys-dip-in-ethan-allen?source=tweet\" data-url=\"https://seekingalpha.com/news/3300881-dougherty-buys-dip-in-ethan-allen\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300874\" data-ts=\"1507894145\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AERI\" target=\"_blank\">AERI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300874-aerie-pharmaceuticals-trading-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aerie Pharmaceuticals trading halted pending news</a></h4><ul><li>Nasdaq has <a href=\"http://www.nasdaqtrader.com/trader.aspx?id=tradehalts\" target=\"_blank\">suspended trading</a> in Aerie Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AERI' title='Aerie Pharmaceuticals, Inc.'>AERI</a>) pending the release of news. Today is the FDA Ad Com review for Rhopressa for lowering intraocular pressure.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3300442-aerie-pharma-breaks-ahead-ad-com-review-rhopressa-lowering-iop-shares-19-percent\" target=\"_blank\">Aerie Pharma breaks out ahead of Ad Com review of Rhopressa for lowering IOP; shares up 19%</a> (Oct. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3300874\" data-linked=\"Aerie Pharmaceuticals trading halted pending news\" data-tweet=\"$AERI - Aerie Pharmaceuticals trading halted pending news https://seekingalpha.com/news/3300874-aerie-pharmaceuticals-trading-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3300874-aerie-pharmaceuticals-trading-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300870\" data-ts=\"1507893193\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DFRG\" target=\"_blank\">DFRG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300870-on-del-friscos-restaurants-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Del Frisco&#39;s Restaurant&#39;s Q3</a></h4><ul>     <li>Del Frisco's Restaurant (NASDAQ:<a href='https://seekingalpha.com/symbol/DFRG' title='Del Frisco&#39;s Restaurant Group'>DFRG</a>) reports total comparable restaurant sales fell 4%&nbsp;in <a href=\"https://seekingalpha.com/pr/16967868-del-frisco-s-restaurant-group-inc-announces-third-quarter-2017-results\" target=\"_blank\">Q3</a>, comprised of a 1.8% decrease in average check and 2.2% decrease in customer counts.</li>     <li>Comp declined 7.7% at&nbsp;Sullivans Steakhouse, 1.1% at&nbsp;Del&nbsp;Frisco's&nbsp;Double Eagle Steak House and 5.4%&nbsp;at Del Friscos Grille.</li>     <li>Del Frisco's&nbsp;Double Eagle Steak House revenue grew 8% to $34.74M.</li>     <li>Sullivan's Steakhouse revenues down 16% to $12.73M.</li>     <li>Del Frisco's Grille revenues increased 7.4% to $25.88M.</li>     <li>Restaurant-level EBITDA as a percentage of sales slipped 250 bps to 14.6%.</li>     <li>G&amp;A expense rate -140 bps to 9%.</li>     <li><b>FY2017 Guidance</b>: Comparable restaurant sales: -2% to -1%;&nbsp;Cost of sales: 28% to 28.4% of revenues;&nbsp;Restaurant-level EBITDA margin: 20.5% to 21%; G&amp;A: ~$27.1M to $28.5M; Tax rate: ~26% to 28%; Capex: $28M to $30M; Adjusted EPS: $0.76 to $0.80.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3300870\" data-linked=\"More on Del Frisco&#39;s Restaurant&#39;s Q3\" data-tweet=\"$DFRG - More on Del Frisco&#39;s Restaurant&#39;s Q3 https://seekingalpha.com/news/3300870-on-del-friscos-restaurants-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3300870-on-del-friscos-restaurants-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300859\" data-ts=\"1507892221\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPTN\" target=\"_blank\">OPTN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300859-optinose-prices-upsized-ipo-16-trading-starts-today\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OptiNose prices upsized IPO at $16, trading starts today</a></h4><ul><li>OptiNose (NASDAQ:<a href='https://seekingalpha.com/symbol/OPTN' title='OptiNose, Inc.'>OPTN</a>) <a href=\"https://seekingalpha.com/pr/16967773-optinose-announces-pricing-initial-public-offering\" target=\"_blank\">prices </a>its IPO of 7.5M shares of common stock at $16 per share, the midpoint of its expected range of $15 - 17. The offering has been increased from the original plan of 6.25M shares.</li><li>Underwriters over-allotment is an additional 1.125M shares. Closing date is October 17.</li><li>Trading commences today.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3299807-optinose-deck-ipo\" target=\"_blank\">OptiNose on deck for IPO</a> (Oct. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3300859\" data-linked=\"OptiNose prices upsized IPO at $16, trading starts today\" data-tweet=\"$OPTN - OptiNose prices upsized IPO at $16, trading starts today https://seekingalpha.com/news/3300859-optinose-prices-upsized-ipo-16-trading-starts-today?source=tweet\" data-url=\"https://seekingalpha.com/news/3300859-optinose-prices-upsized-ipo-16-trading-starts-today\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300852\" data-ts=\"1507890078\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANAB\" target=\"_blank\">ANAB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300852-anaptysbio-prices-public-offering-of-common-stock\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AnaptysBio prices public offering of common stock</a></h4><ul> <li>AnaptysBio (NASDAQ:<a href='https://seekingalpha.com/symbol/ANAB' title='AnaptysBio'>ANAB</a>) <a href=\"https://seekingalpha.com/pr/16967744-anaptysbio-announces-pricing-public-offering\" target=\"_blank\">prices</a> its public offering of 3M shares of common stock at a price of $68.50 per share yielding gross proceeds of ~$205.5M.</li><li>Underwriters are&nbsp;granted a 30-day option to purchase up to an additional 450,000 shares.</li><li>Closing date is October 17.</li><li>Shares are down&nbsp;<font color='red'>1%</font>&nbsp;premarket on light volume. Yesterday's close was $70.80.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3300852\" data-linked=\"AnaptysBio prices public offering of common stock\" data-tweet=\"$ANAB - AnaptysBio prices public offering of common stock https://seekingalpha.com/news/3300852-anaptysbio-prices-public-offering-of-common-stock?source=tweet\" data-url=\"https://seekingalpha.com/news/3300852-anaptysbio-prices-public-offering-of-common-stock\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300838\" data-ts=\"1507877249\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HPQ\" target=\"_blank\">HPQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300838-hp-serves-up-bullish-2018-earnings-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HP serves up bullish 2018 earnings guidance</a></h4><ul>     <li>HP Inc. (NYSE:<a href='https://seekingalpha.com/symbol/HPQ' title='HP Inc.'>HPQ</a>) offered <a href=\"https://seekingalpha.com/pr/16967759-hp-inc-announces-fiscal-2018-financial-outlook\" target=\"_blank\">upbeat 2018 earnings guidance</a> following yesterday&rsquo;s close, sending shares <font color='green'>+2.4%</font> after-hours.</li>     <li>HP expects EPS of $1.74-$1.84 in FY 2018 ending in October, compared with the $1.76 analyst consensus estimate, and it foresees 2018 free cash flow of at least $3B with plans to return 50%-75% of the amount to shareholders through dividends and stock buybacks; the board also approved a 5% increase in the quarterly dividend.</li>     <li>HP has been <a href=\"http://www.marketwatch.com/story/hp-says-it-expects-a-profitable-2018-2017-10-12\" target=\"_blank\">gaining market share</a> in worldwide PC shipments, as it battles with Lenovo (<a href='https://seekingalpha.com/symbol/LNVGY' title='Lenovo Group Ltd. ADR'>OTCPK:LNVGY</a>, <a href='https://seekingalpha.com/symbol/LNVGF' title='Lenovo Group Ltd.'>OTCPK:LNVGF</a>) for the title of largest maker of personal computers, while focusing on higher-profit segments such as gaming and convertible laptops.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3300838\" data-linked=\"HP serves up bullish 2018 earnings guidance\" data-tweet=\"$HPQ $HPQ $LNVGY - HP serves up bullish 2018 earnings guidance https://seekingalpha.com/news/3300838-hp-serves-up-bullish-2018-earnings-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3300838-hp-serves-up-bullish-2018-earnings-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":67,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}